<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery - Blessberger, H - 2019 | Cochrane Library</title> <meta content="Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery - Blessberger, H - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013435/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery - Blessberger, H - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013435/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013435" name="dc.identifier" scheme="DOI"/> <meta content="Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery" name="citation_title"/> <meta content="Hermann Blessberger" name="citation_author"/> <meta content="Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz" name="citation_author_institution"/> <meta content="hermann.blessberger@kepleruniklinikum.at" name="citation_author_email"/> <meta content="Sharon R Lewis" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Michael W Pritchard" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Lizzy J Fawcett" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Hans Domanovits" name="citation_author"/> <meta content="Vienna General Hospital, Medical University of Vienna" name="citation_author_institution"/> <meta content="Oliver Schlager" name="citation_author"/> <meta content="Vienna General Hospital, Medical University of Vienna" name="citation_author_institution"/> <meta content="Brigitte Wildner" name="citation_author"/> <meta content="University Library of the Medical University of Vienna" name="citation_author_institution"/> <meta content="Juergen Kammler" name="citation_author"/> <meta content="Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz" name="citation_author_institution"/> <meta content="Clemens Steinwender" name="citation_author"/> <meta content="Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD013435" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/09/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013435/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013435/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013435/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cardiac Surgical Procedures [adverse effects, mortality]; Adrenergic beta‐Antagonists [adverse effects, *therapeutic use]; Arrhythmias, Cardiac [mortality, prevention &amp; control]; Bradycardia [chemically induced]; Cerebrovascular Disorders [mortality, prevention &amp; control]; Hypotension [chemically induced, mortality, prevention &amp; control]; Morbidity; Myocardial Infarction [mortality, prevention &amp; control]; Myocardial Ischemia [mortality, prevention &amp; control]; Perioperative Care [*methods]; Postoperative Complications [mortality, prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013435&amp;doi=10.1002/14651858.CD013435&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013435\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013435\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013435\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ko","ms","fa","fr","zh_HANS","hr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013435",title:"Perioperative beta\\u2010blockers for preventing surgery\\u2010related mortality and morbidity in adults undergoing cardiac surgery",firstPublishedDate:"Sep 23, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013435&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013435';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013435/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013435/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013435%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013435/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013435/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013435/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013435/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013435" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013435/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013435" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013435/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013435/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5855 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013435" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0121"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0074"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-sec-0115"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013435/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/appendices#CD013435-sec-0126"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/table_n/CD013435StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/table_n/CD013435StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013435/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013435/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013435/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013435/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013435/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Hermann Blessberger</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0003">Sharon R Lewis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0004">Michael W Pritchard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0005">Lizzy J Fawcett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0006">Hans Domanovits</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0007">Oliver Schlager</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0008">Brigitte Wildner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0009">Juergen Kammler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013435/information#CD013435-cr-0010">Clemens Steinwender</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013435/information/en#CD013435-sec-0139">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 September 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013435/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013435">https://doi.org/10.1002/14651858.CD013435</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013435-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013435-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013435-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013435-abs-0002">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013435-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013435-abs-0001" lang="en"> <section id="CD013435-sec-0001"> <h3 class="title" id="CD013435-sec-0001">Background</h3> <p>Randomized controlled trials (RCTs) have yielded conflicting results regarding the ability of beta‐blockers to influence perioperative cardiovascular morbidity and mortality. Thus routine prescription of these drugs in unselected patients remains a controversial issue. A previous version of this review assessing the effectiveness of perioperative beta‐blockers in cardiac and non‐cardiac surgery was last published in 2018. The previous review has now been split into two reviews according to type of surgery. This is an update and assesses the evidence in cardiac surgery only. </p> </section> <section id="CD013435-sec-0002"> <h3 class="title" id="CD013435-sec-0002">Objectives</h3> <p>To assess the effectiveness of perioperatively administered beta‐blockers for the prevention of surgery‐related mortality and morbidity in adults undergoing cardiac surgery. </p> </section> <section id="CD013435-sec-0003"> <h3 class="title" id="CD013435-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, CINAHL, Biosis Previews and Conference Proceedings Citation Index‐Science on 28 June 2019. We searched clinical trials registers and grey literature, and conducted backward‐ and forward‐citation searching of relevant articles. </p> </section> <section id="CD013435-sec-0004"> <h3 class="title" id="CD013435-sec-0004">Selection criteria</h3> <p>We included RCTs and quasi‐randomized studies comparing beta‐blockers with a control (placebo or standard care) administered during the perioperative period to adults undergoing cardiac surgery. We excluded studies in which all participants in the standard care control group were given a pharmacological agent that was not given to participants in the intervention group, studies in which all participants in the control group were given a beta‐blocker, and studies in which beta‐blockers were given with an additional agent (e.g. magnesium). We excluded studies that did not measure or report review outcomes. </p> </section> <section id="CD013435-sec-0005"> <h3 class="title" id="CD013435-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for inclusion, extracted data, and assessed risks of bias. We assessed the certainty of evidence with GRADE. </p> </section> <section id="CD013435-sec-0006"> <h3 class="title" id="CD013435-sec-0006">Main results</h3> <p>We included 63 studies with 7768 participants; six studies were quasi‐randomized and the remaining were RCTs. All participants were undergoing cardiac surgery, and in most studies, at least some of the participants were previously taking beta‐blockers. Types of beta‐blockers were: propranolol, metoprolol, sotalol, esmolol, landiolol, acebutolol, timolol, carvedilol, nadolol, and atenolol. In twelve studies, beta‐blockers were titrated according to heart rate or blood pressure. Duration of administration varied between studies, as did the time at which drugs were administered; in nine studies this was before surgery, in 20 studies during surgery, and in the remaining studies beta‐blockers were started postoperatively. Overall, we found that most studies did not report sufficient details for us to adequately assess risk of bias. In particular, few studies reported methods used to randomize participants to groups. In some studies, participants in the control group were given beta‐blockers as rescue therapy during the study period, and all studies in which the control was standard care were at high risk of performance bias because of the open‐label study design. No studies were prospectively registered with clinical trials registers, which limited the assessment of reporting bias. We judged 68% studies to be at high risk of bias in at least one domain. </p> <p>Study authors reported few deaths (7 per 1000 in both the intervention and control groups), and we found low‐certainty evidence that beta‐blockers may make little or no difference to all‐cause mortality at 30 days (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.47 to 1.90; 29 studies, 4099 participants). For myocardial infarctions, we found no evidence of a difference in events (RR 1.05, 95% CI 0.72 to 1.52; 25 studies, 3946 participants; low‐certainty evidence). Few study authors reported cerebrovascular events, and the evidence was uncertain (RR 1.37, 95% CI 0.51 to 3.67; 5 studies, 1471 participants; very low‐certainty evidence). Based on a control risk of 54 per 1000, we found low‐certainty evidence that beta‐blockers may reduce episodes of ventricular arrhythmias by 32 episodes per 1000 (RR 0.40, 95% CI 0.25 to 0.63; 12 studies, 2296 participants). For atrial fibrillation or flutter, there may be 163 fewer incidences with beta‐blockers, based on a control risk of 327 incidences per 1000 (RR 0.50, 95% CI 0.42 to 0.59; 40 studies, 5650 participants; low‐certainty evidence). However, the evidence for bradycardia and hypotension was less certain. We found that beta‐blockers may make little or no difference to bradycardia (RR 1.63, 95% CI 0.92 to 2.91; 12 studies, 1640 participants; low‐certainty evidence), or hypotension (RR 1.84, 95% CI 0.89 to 3.80; 10 studies, 1538 participants; low‐certainty evidence). </p> <p>We used GRADE to downgrade the certainty of evidence. Owing to studies at high risk of bias in at least one domain, we downgraded each outcome for study limitations. Based on effect size calculations in the previous review, we found an insufficient number of participants in all outcomes (except atrial fibrillation) and, for some outcomes, we noted a wide confidence interval; therefore, we also downgraded outcomes owing to imprecision. The evidence for atrial fibrillation and length of hospital stay had a moderate level of statistical heterogeneity which we could not explain, and we, therefore, downgraded these outcomes for inconsistency. </p> </section> <section id="CD013435-sec-0007"> <h3 class="title" id="CD013435-sec-0007">Authors' conclusions</h3> <p>We found no evidence of a difference in early all‐cause mortality, myocardial infarction, cerebrovascular events, hypotension and bradycardia. However, there may be a reduction in atrial fibrillation and ventricular arrhythmias when beta‐blockers are used. A larger sample size is likely to increase the certainty of this evidence. Four studies awaiting classification may alter the conclusions of this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013435-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013435-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013435-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013435-abs-0014">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013435-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013435-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013435-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013435-abs-0006" lang="en"> <h3>Beta‐blockers to prevent death or serious events after heart surgery</h3> <p>This review assessed evidence of whether beta‐blockers given around the time of surgery can reduce death or other serious events for people undergoing heart surgery. </p> <p><b>Background</b> </p> <p>People undergoing heart surgery are at greater risk of complications and death. Heart surgery increases the amount of stress in the body, causing the release of the hormones adrenaline and noradrenaline. This stress can lead to serious events including death, heart attacks, stroke, or an irregular heartbeat. Beta‐blockers are drugs that block the action of adrenaline and noradrenaline on the heart. Beta‐blockers can slow down the heart and reduce blood pressure, and this effect may reduce the risk of serious events. However, they can also lead to a very low heart rate or very low blood pressure, and this effect may increase the risk of death or a stroke. Prevention of complications around the time of surgery is an important safety consideration for people undergoing heart surgery. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to 28 June 2019. We included 63 studies with 7768 adults who were undergoing heart surgery, including coronary artery bypass graft and valve replacement surgery. Studies were mostly randomized controlled studies, and six were quasi‐randomized (participants were allocated to groups by methods such as using hospital record numbers or dates of birth). The types of beta‐blockers were: propranolol, metoprolol, sotalol, esmolol, landiolol, acebutolol, timolol, carvedilol, nadolol, and atenolol. These beta‐blockers were compared with either a placebo (disguised to look like a beta‐blocker but containing no medicine) or with standard care. Beta‐blockers were started before surgery, during surgery or at the latest by the end of the first day after surgery. The length of time beta‐blockers were given varied between studies. In most studies, at least some of the people were already taking beta‐blockers, which would be expected for people who had conditions that needed heart surgery. </p> <p><b>Key results</b> </p> <p>Beta‐blockers probably make little or no difference to the number of people who die (29 studies, 4099 participants) or have a heart attack (25 studies, 3946 participants) within 30 days of surgery. This was supported by low‐certainty evidence. Few studies reported on people who had a stroke, and we were uncertain whether or not beta‐blockers reduced strokes because the certainty of the evidence was very low (5 studies, 1471 participants). Beta‐blockers may reduce atrial fibrillation, which is an irregular heartbeat starting in the atrial chambers of the heart that increases the risk of stroke if untreated (40 studies, 5650 participants; low‐certainty evidence). Beta‐blockers may also reduce ventricular arrhythmias, which are potentially life‐threatening irregular heartbeat rhythms originating in the main chambers of the heart, and which may need immediate medical treatment (12 studies, 2296 participants). We found that beta‐blockers may make little or no difference to whether people experience a very low heart rate or very low blood pressure. </p> <p>We were uncertain whether beta‐blockers made a difference to the number of deaths up to a year after surgery (3 studies, 511 participants), to death because of the heart (4 studies, 320 participants), or to people who had heart failure (3 studies, 311 participants). The certainty of this evidence was very low. People who took beta‐blockers had a shorter hospital stay by about half a day (14 studies, 2450 participants; low‐certainty evidence). </p> <p>No studies assessed whether people on beta‐blockers had a better quality of life after heart surgery. </p> <p><b>Certainty of the evidence</b> </p> <p>The certainty of the evidence in this review was mostly low. We found that many studies reported methods that we believed could influence the results. For example, many studies did not use a placebo‐control and the doctors might, therefore, have treated people differently in each group. We were unable to explain some of the differences that we found in the data for atrial fibrillation. We also needed to have evidence from a larger number of participants to be very confident in our findings. </p> <p><b>Conclusion</b> </p> <p>Beta‐blockers may be beneficial for people who are undergoing cardiac surgery because they may reduce the number of people who experience atrial fibrillation and ventricular arrhythmias. Beta‐blockers may make little or no difference to the other outcomes in this review, including death, heart attacks or stroke. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013435-sec-0121" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-sec-0121">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-sec-0172">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013435-sec-0121"></div> <h3 class="title" id="CD013435-sec-0122">Implications for practice</h3> <section id="CD013435-sec-0122"> <p>We found no evidence of a difference in early all‐cause mortality, myocardial infarction, cerebrovascular events, hypotension and bradycardia. However, our evidence showed a reduction in atrial fibrillation when beta‐blockers were used, and they probably also reduce ventricular arrhythmias. A larger sample size would increase the certainty of this evidence. Four studies awaiting classification may alter the conclusion of this review. </p> </section> <h3 class="title" id="CD013435-sec-0123">Implications for research</h3> <section id="CD013435-sec-0123"> <p>In order to increase the certainty in the effects for most outcomes in this review, a larger sample is required. More research in this field would also enable a more precise exploration of subgroups. In particular, the timing of beta‐blocker application may have an important influence on their effect (plaque stabilization, haemodynamic adaptation). </p> <p>We noted that no studies measured quality of life. From a patient perspective, this is likely an important outcome, and from a study investigator perspective, evaluation can be conducted easily using established questionnaires. We suggest that future trials should also focus their attention on this endpoint. </p> <p>The review assessed only direct comparisons. Given the different types of beta‐blockers, and continuing research that we expect to contribute to this field, a network meta‐analysis should be considered in future review updates. A network meta‐analysis would explore indirect comparisons, as well as direct comparisons, and may be useful to clinicians by providing a more comprehensive analysis of the effects of each type of beta‐blocker, and further improve the precision of the estimates. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013435-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013435-sec-0043"></div> <div class="table" id="CD013435-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Beta‐blockers compared to placebo or standard care for preventing perioperative mortality and morbidity in adults undergoing cardiac surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Population:</b> adults undergoing cardiac surgery under general anaesthesia<br/> <b>Setting:</b> hospitals in: Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, UK, USA<br/> <b>Intervention:</b> beta‐blockers (metoprolol, propranolol, sotalol, esmolol, timolol, landiolol, nadolol, acebutolol, atenolol)<br/> <b>Comparison:</b> placebo or standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with beta‐blockers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95</p> <p>(0.47 to 1.90)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4099<br/> (29 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000<br/> (3 to 14) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acute myocardial infarction</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.72 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3946<br/> (25 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/> (21 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cerebrovascular events</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(RR 1.37, 95% CI 0.51 to 3.67)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1471<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000<br/> (5 to 36) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Ventricular arrhythmias</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/> (0.25 to 0.63) </p> <p>NNTB: 31 (25 to 50)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2296<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (13 to 34) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Atrial fibrillation or flutter, or both</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/> (0.42 to 0.59) </p> <p>NNTB: 6 (5 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5650<br/> (40 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>327 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>164 per 1000<br/> (137 to 193) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Bradycardia</b> </p> <p>(within 30 days; as defined by study authors, minimum heart rate &lt; 60 beats per minute or requiring medication) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.63<br/> (0.92 to 2.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1640<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000<br/> (27 to 87) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypotension</b> </p> <p>(within 30 days; as defined by study authors, minimum systolic blood pressure &lt; 90 mmHg or requiring medication) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.84<br/> (0.89 to 3.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1538<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (14 to 58) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>NNTB:</b> number needed to treat for an additional beneficial outcome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain; and one level for imprecision owing to a wide CI in the effect estimate and because the evidence was from too few participants; our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>).<br/> <sup>b</sup>We downgraded by three levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and two levels for imprecision owing to the very wide CI in the effect estimate and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>).<br/> <sup>c</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and one level for imprecision because the evidence was from too few participants; our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>).<br/> <sup>d</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and one level for inconsistency owing to moderate level of statistical heterogeneity which we were unable to explain through subgroup analysis.<br/> <sup>e</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain; and one level for imprecision owing to the very wide confidence interval and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013435-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-sec-0044">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-sec-0152">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD013435-sec-0044"></div> <section id="CD013435-sec-0045"> <h3 class="title" id="CD013435-sec-0045">Description of the condition</h3> <p>Cardiovascular mortality and morbidity are prevalent and costly in people undergoing cardiac surgery, and prevention of early postoperative complications remains a major issue (<a href="./references#CD013435-bbs2-0106" title="OpreaAD , LombardFW , KertaiMD . Perioperative beta‐adrenergic blockade in noncardiac and cardiac surgery: a clinical update. Journal of Cardiothoracic and Vascular Anesthesia2019;33(3):817‐32. [PUBMED: 29934209] ">Oprea 2019</a>). Surgery for acquired cardiac disease has a mortality rate of up to 1% to 4% (<a href="./references#CD013435-bbs2-0108" title="SanagouM , WolfeR , ForbesA , ReidCM . Hospital‐level associations with 30‐day patient mortality after cardiac surgery: a tutorial on the application and interpretation of marginal and multilevel logistic regression. BMC Medical Research Methodology2012;12(28):1‐10. [PUBMED: 22409732] ">Sanagou 2012</a>; <a href="./references#CD013435-bbs2-0109" title="Society for Cardiothoracic Surgery in Great Britain &amp; Ireland. Blue Book Online. www.bluebook.scts.org (accessed 22 August 2019). ">SCTS 2015</a>), a perioperative myocardial infarction rate up to 9% (<a href="./references#CD013435-bbs2-0084" title="ChenJC , KaulP , HaverichA , MenascheP , SmithPK , CarrierM , et al. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Critical Care Medicine2007;35(5):1296‐301. [PUBMED: 17414091] ">Chen 2007</a>) and overall complication rates of 15%, depending on the type of operation and a person's co‐morbidities (<a href="./references#CD013435-bbs2-0086" title="CrawfordTC , MagruderJT , GrimmJC , Suarez‐PierreA , SciortinoCM , MandalK , et al. Complications after cardiac operations: all are not created equal. Annals of Thoracic Surgery2017;103:32‐40. [PUBMED: 27884410] ">Crawford 2017</a>). </p> </section> <section id="CD013435-sec-0046"> <h3 class="title" id="CD013435-sec-0046">Description of the intervention</h3> <p>There are various pharmacological agents that may be used to protect people undergoing surgery against adverse cardiovascular events (<a href="./references#CD013435-bbs2-0103" title="LewisSR , PritchardMW , Schofield‐RobinsonOJ , AldersonP , SmithAF . Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery. Cochrane Database of Systematic Reviews2018, Issue 7. [DOI: 10.1002/14651858.CD012584.pub2] ">Lewis 2018</a>), and alpha‐2 adrenergic agents have also been evaluated for their use perioperatively (<a href="./references#CD013435-bbs2-0090" title="DuncanD , SankarA , BeattieW , WijeysunderaDN . Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004126.pub3] ">Duncan 2018</a>). In addition, the choice of anaesthetic drugs and techniques can also affect cardiovascular outcomes (<a href="./references#CD013435-bbs2-0101" title="HristovskaAM , DuchP , AllingstrupM , AfshariA . Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database of Systematic Reviews2017, Issue 8. [DOI: 10.1002/14651858.CD012763] ">Hristovska 2017</a>). </p> <p>This review, however, evaluates the effectiveness of beta‐adrenoceptor blocking agents, or beta‐blockers, for this purpose. These pharmacological agents block the actions of the stress hormones epinephrine (adrenaline) and norepinephrine (noradrenaline). They are typically used to manage abnormal heart rhythms, heart failure, coronary heart disease, and their effectiveness has been assessed for hypertension (<a href="./references#CD013435-bbs2-0115" title="WiysongeCS , BradleyHA , VolminkJ , MayosiBM , OpieLH . Beta‐blockers for hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD002003.pub5] ">Wiysonge 2017</a>) and for secondary prevention of stroke (<a href="./references#CD013435-bbs2-0088" title="DeLimaLG , SaconatoH , AtallahÁN , daSilvaEM . Beta‐blockers for preventing stroke recurrence. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD007890.pub3] ">De Lima 2014</a>). </p> </section> <section id="CD013435-sec-0047"> <h3 class="title" id="CD013435-sec-0047">How the intervention might work</h3> <p>Cardiac adverse events appear to be related to the persistently exaggerated sympathetic response that is associated with substantial increases in heart rate and myocardial oxygen consumption. Drugs that block beta‐adrenergic receptors, and thus the sympathetic response, are capable of preventing cardiac complications in people with acute myocardial infarction, silent ischaemia and heart failure (<a href="./references#CD013435-bbs2-0106" title="OpreaAD , LombardFW , KertaiMD . Perioperative beta‐adrenergic blockade in noncardiac and cardiac surgery: a clinical update. Journal of Cardiothoracic and Vascular Anesthesia2019;33(3):817‐32. [PUBMED: 29934209] ">Oprea 2019</a>; <a href="./references#CD013435-bbs2-0112" title="ThaperA , KulikA . Rationale for administering beta‐blocker therapy to patients undergoing coronary artery bypass surgery: a systematic review. Expert Opinion on Drug Safety2018;17(8):805‐13. [PUBMED: 30037300] ">Thaper 2018</a>). Perioperative blockade of beta‐adrenergic receptors, therefore, has been proposed to reduce the risk of perioperative complications in people after cardiac surgery but its routine use is still a matter of debate (<a href="./references#CD013435-bbs2-0110" title="Sousa‐UvaM , HeadSJ , MilojevicM , ColletJP , LandoniG , CastellaM , et al. 2017 EACTS guidelines on perioperative medication in adult cardiac surgery. European Journal of Cardio‐Thoracic Surgery2018;53(1):5‐33. [PUBMED: 29029110] ">Sousa‐Uva 2017</a>). </p> </section> <section id="CD013435-sec-0048"> <h3 class="title" id="CD013435-sec-0048">Why it is important to do this review</h3> <p>Current guidelines on the use of beta‐blockers in aortocoronary bypass surgery suggest that people with an ejection fraction greater than 30% should receive beta‐blockers preoperatively to reduce in‐hospital mortality (<a href="./references#CD013435-bbs2-0100" title="HillisLD , SmithPK , AndersonJL , BittlJA , BridgesCR , ByrneJG , et al. 2011 ACCF/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation2011;124(23):e652‐e735. [PUBMED: 22064599] ">Hillis 2011</a>). This class IIa recommendation was based on smaller RCTs and observational studies indicating reduced mortality with the use of beta‐blockers in bypass surgery. Besides this, all people undergoing aortocoronary bypass surgery are diagnosed with coronary heart disease and therefore should receive beta‐blockers if not contraindicated for other reasons (class Ia recommendation; <a href="./references#CD013435-bbs2-0104" title="MontalescotG , SechtemU , AchenbachS , AndreottiF , ArdenC , BudajA , et al. 2013 ESC guidelines in the management of stable coronary artery disease. European Heart Journal2013;34(38):2949‐3003. [PUBMED: 23996286] ">Montalescot 2013</a>). However, evidence from a previous version of this review evaluating all‐cause mortality within 30 days demonstrated little or no difference in mortality for people undergoing cardiac surgery (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). We aim to incorporate new evidence into this review, to increase the certainty of the effect of beta‐blockers in this population. </p> <p>Our previous review assessed the effectiveness of beta‐blockers in both cardiac and non‐cardiac surgery (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). The previous review has now been split into two reviews according to type of surgery. This is an update, in which we assess the evidence in cardiac surgery only. We report the evidence for non‐cardiac surgery elsewhere (<a href="./references#CD013435-bbs2-0082" title="BlessbergerH , LewisSR , PritchardMW , FawcettLJ , DomanovitsH , SchlagerO , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery. Cochrane Database of Systematic Reviews2019, Issue 9. [DOI: 10.1002/14651858.CD013438] ">Blessberger 2019</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013435-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-sec-0049">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-sec-0157">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013435-sec-0049"></div> <p>To assess the effectiveness of perioperatively administered beta‐blockers for the prevention of surgery‐related mortality and morbidity in adults undergoing cardiac surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013435-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-sec-0050">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-sec-0158">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013435-sec-0050"></div> <section id="CD013435-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013435-sec-0052"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) and quasi‐randomized studies in which investigators used methods to allocate participants to groups such as hospital record number or date of birth. </p> </section> <section id="CD013435-sec-0053"> <h4 class="title">Types of participants</h4> <p>We included studies that assessed the effects of beta‐blockers on adults who were 18 years of age or older and who were undergoing cardiac surgery under general anaesthesia. </p> </section> <section id="CD013435-sec-0054"> <h4 class="title">Types of interventions</h4> <p>We included studies in which beta‐adrenoceptor‐blockers (beta‐blockers) were administered during the perioperative period; we defined the perioperative period as 30 days before surgery to 30 days after surgery. Beta‐blockers could be started before surgery, during surgery or at the latest by the end of the first day after surgery. Beta‐blockers were given intravenously, orally or via a feeding tube, and were compared with a control (placebo or standard care). We excluded studies in which all participants in the standard care control group were given a pharmacological agent that was not given to participants in the intervention group; similarly, we excluded studies in which all participants in the control group were given a beta‐blocker. </p> <p>We excluded studies (or intervention groups within a multi‐arm study) in which the beta‐blocker was given with a supplementary agent (e.g. magnesium) unless the agent was given in both groups as part of standard care management. </p> </section> <section id="CD013435-sec-0055"> <h4 class="title">Types of outcome measures</h4> <p>We excluded studies that did not measure review outcomes (see <a href="#CD013435-sec-0143">Differences between protocol and review</a>). Except for long‐term all‐cause mortality, length of hospital stay, and quality of life, we aimed to collect outcome data that were measured within 30 days postoperatively or before hospital discharge (whichever occurred later). We removed some outcomes in this update (see <a href="#CD013435-sec-0143">Differences between protocol and review</a>). </p> <section id="CD013435-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013435-list-0001"> <li> <p>Early all‐cause mortality</p> </li> </ul> </p> </section> <section id="CD013435-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013435-list-0002"> <li> <p>Long‐term all‐cause mortality, occurring later than 30 days postoperatively</p> </li> <li> <p>Death due to cardiac causes</p> </li> <li> <p>Acute myocardial infarction, as defined by study authors. We included only non‐fatal myocardial infarctions if a distinction was possible. </p> </li> <li> <p>Cerebrovascular events: transient ischaemic attack (TIA), prolonged reversible ischaemic neurological deficit (PRIND), or stroke, as defined by study authors. We included only non‐fatal cerebrovascular events if a distinction was possible. </p> </li> <li> <p>Ventricular arrhythmias: ventricular tachycardias and ventricular fibrillation</p> </li> <li> <p>Atrial fibrillation or atrial flutter (or both)</p> </li> <li> <p>Bradycardia, as defined by study authors (minimum criteria: below 60 beats per minute or requiring medical intervention) </p> </li> <li> <p>Hypotension, as defined by study authors (minimum criteria: below 90 mmHg systolic blood pressure or requiring medical intervention) </p> </li> <li> <p>Congestive heart failure, as defined by study authors</p> </li> <li> <p>Length of hospital stay</p> </li> <li> <p>Quality of life, as defined by study authors</p> </li> </ul> </p> </section> </section> </section> <section id="CD013435-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013435-sec-0059"> <h4 class="title">Electronic searches</h4> <p>We identified RCTs through literature searching with systematic and sensitive search strategies, as outlined in Chapter 6.4 of the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013435-bbs2-0102" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Lefebvre 2011</a>). We applied no restrictions to language or publication status. We searched the following databases for relevant trials: </p> <p> <ul id="CD013435-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2019; Issue 6) in the Cochrane Library (searched 28 June 2019); </p> </li> <li> <p>MEDLINE (Ovid SP; 1946 to 28 June 2019);</p> </li> <li> <p>Embase (Ovid SP; 1974 to 28 June 2019);</p> </li> <li> <p>CINAHL (EBSCOhost: 1981 to 28 June 2019);</p> </li> <li> <p>Biosis Previews (1969 to 28 June 2019);</p> </li> <li> <p>Web of Science (SCI‐EXPANDED; 1900 to 28 June 2019);</p> </li> <li> <p>Conference Proceedings Citation Index‐Science (CPCI‐S; 1990 to 28 June 2019).</p> </li> </ul> </p> <p>We developed a subject‐specific search strategy in MEDLINE and other listed databases, in consultation with the Information Specialist for Cochrane Anaesthesia. We subtracted the previous review's search results (up to and including 2012) from the new search. Search strategies can be found in: <a href="./appendices#CD013435-sec-0127">Appendix 1</a>; <a href="./appendices#CD013435-sec-0128">Appendix 2</a>; <a href="./appendices#CD013435-sec-0129">Appendix 3</a>; <a href="./appendices#CD013435-sec-0130">Appendix 4</a>; <a href="./appendices#CD013435-sec-0131">Appendix 5</a>; <a href="./appendices#CD013435-sec-0132">Appendix 6</a>; <a href="./appendices#CD013435-sec-0133">Appendix 7</a>. </p> <p>We scanned the following clinical trials registers for ongoing and unpublished trials:</p> <p> <ul id="CD013435-list-0004"> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>) on 22 March 2019; </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) on 22 March 2019. </p> </li> </ul> </p> </section> <section id="CD013435-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We carried out citation searching of identified included studies published since 2012 in Web of Science on 22 March 2019 (<a href="http://apps.webofknowledge.com" target="_blank">apps.webofknowledge.com</a>). We conducted a search of grey literature using Opengrey on 5 April 2019 (<a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu/</a>). In addition, we scanned reference lists of relevant systematic reviews which were published since 2015. </p> </section> </section> <section id="CD013435-sec-0061"> <h3 class="title" id="CD013435-sec-0061">Data collection and analysis</h3> <p>Two review authors (SL, and LF or MP) independently selected studies and extracted data from new included studies. We compared decisions at each stage. In cases of disagreement, we reassessed the respective studies to reach consensus, and if necessary included a third review author (HB) for resolution. </p> <section id="CD013435-sec-0062"> <h4 class="title">Selection of studies</h4> <p>We used reference management software to collate the results of searches and to remove duplicates (<a href="./references#CD013435-bbs2-0092" title="ThomsonReuters . Endnote X5. Philadelphia (PA): Thomson Reuters, 2011. ">Endnote</a>). We used <a href="./references#CD013435-bbs2-0085" title="Veritas Health Innovation. Covidence. Version accessed 2 January 2019. Melbourne, Australia: Veritas Health Innovation. ">Covidence 2019</a> software to screen results of the search of titles and abstracts and to identify potentially relevant studies. We sourced the full texts of all potentially relevant studies and considered whether they met the inclusion criteria (see <a href="#CD013435-sec-0051">Criteria for considering studies for this review</a>). We reviewed abstracts at this stage and included them in the review only if they provided sufficient information and relevant results that included denominator figures for the intervention and control groups. We recorded the number of papers retrieved at each stage and report this information using a PRISMA flow chart (see Figure 1). We report in the review brief details of closely related but excluded papers. </p> </section> <section id="CD013435-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>We used a data extraction form to collect information and outcome data from studies (<a href="./appendices#CD013435-sec-0134">Appendix 8</a>). We collected the following information. </p> <p> <ul id="CD013435-list-0005"> <li> <p>Methods: type of study design, setting, dates of study, funding sources and study author declarations of interest </p> </li> <li> <p>Participants: number randomized to each group; number of losses; number analysed in each group and whether intention‐to‐treat analysis was used; baseline characteristics (age, gender, American Society of Anesthesiologists (ASA) grade of other measure of health status, type of surgery, history of coronary heart disease, myocardial infarction, hypertension, reduced ejection fraction, chronic obstructive pulmonary disease (COPD), preoperative use of beta‐blockers) </p> </li> <li> <p>Intervention: details of beta‐blocker (type; dose; time; duration; route of administration; goal‐directed or fixed‐dose), and details of control (placebo or standard care) </p> </li> <li> <p>Outcomes: data for all reported review outcomes including study author definitions, measurement tools, and time points. </p> </li> </ul> </p> <p>We considered the applicability of information from individual studies and generalizability of the data to our intended study population (i.e. the potential for indirectness in our review). </p> <p>In multi‐arm studies, we did not collect data on any groups that were not eligible for inclusion in the review. </p> </section> <section id="CD013435-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed study quality, study limitations, and the extent of potential bias using the Cochrane 'Risk of bias' tool (<a href="./references#CD013435-bbs2-0099" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available fromwww.training.cochrane.org/handbook. ">Higgins 2017</a>). We assessed the following domains. </p> <p> <ul id="CD013435-list-0006"> <li> <p>Sequence generation (selection bias)</p> </li> <li> <p>Allocation concealment (selection bias)</p> </li> <li> <p>Blinding of participants, personnel, and outcomes assessors (performance and detection bias) </p> </li> <li> <p>Incomplete outcome data (attrition bias)</p> </li> <li> <p>Selective outcome reporting (reporting bias)</p> </li> <li> <p>Other risks of bias</p> </li> </ul> </p> <p>For each domain, two review authors (SL, and MP or LF) judged whether study authors made sufficient attempts to minimize bias in their study design. We made judgements using three measures ‐ high, low, or unclear risk of bias. We recorded this in 'Risk of bias' tables and present summary 'Risk of bias' figures (see Figure 2 and Figure 3). </p> <p>For other risks of bias, we considered the effect of beta‐blockers given as 'rescue therapy' to treat specified conditions. We judged studies to have a high risk of other bias if administration of such 'rescue therapy' had the potential to influence outcome data. </p> </section> <section id="CD013435-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <p>We collected dichotomous data for mortality outcomes, acute myocardial infarction, cerebrovascular events, ventricular arrhythmias, atrial fibrillation and atrial flutter, bradycardia, hypotension, and congestive heart failure. We collected continuous data for length of hospital stay. </p> <p>For dichotomous data, we reported risk ratios (RRs) to compare groups, and continuous data as mean difference (MDs). We reported 95% confidence intervals (CIs). </p> </section> <section id="CD013435-sec-0066"> <h4 class="title">Unit of analysis issues</h4> <p>For multi‐arm studies, which included different types of beta‐blockers or different doses of beta‐blockers, we combined dichotomous data to create a single beta‐blocker group, and we used these composite data in the primary analysis. During subgroup analysis by type of beta‐blocker, we included data separately for each type of beta‐blocker, and used the 'halving method' with data in the control group to avoid a unit of analysis error (<a href="./references#CD013435-bbs2-0089" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> <p>If multi‐arm studies had included continuous data for length of stay, we planned to calculate combined mean and standard deviation values according to the formula provided in Chapter 7.7.3.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013435-bbs2-0098" title="HigginsJP , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD013435-sec-0067"> <h4 class="title">Dealing with missing data</h4> <p>If information on both study group allocation and respective outcomes was available, we re‐included withdrawn participants in keeping with the intention‐to‐treat principle. If information was not available, we performed an available case analysis. We did not perform imputation techniques. </p> <p>We excluded continuous data assessing length of stay if a range of dispersion (standard deviation or standard error) was not provided along with mean values. When both measures of spread (standard deviation and standard error) were presented, we used the standard deviation as the measure of choice. We did not apply imputation techniques. </p> <p>We attempted contact with some study authors for additional information; we reported this information in the Notes section of the <a href="./references#CD013435-sec-0148" title="">Characteristics of included studies</a>. </p> </section> <section id="CD013435-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed whether evidence of inconsistency was apparent in our results by considering heterogeneity. We assessed clinical and methodological heterogeneity by comparing similarities in our included studies between study designs, participants, interventions, and outcomes, and used the data collected from the full‐text reports (as stated in <a href="#CD013435-sec-0061">Data collection and analysis</a>). We explored clinical and methodological heterogeneity through subgroup analysis. We assessed statistical heterogeneity by calculating the Chi<sup>2</sup> test or I<sup>2</sup> statistic (<a href="./references#CD013435-bbs2-0097" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>), and judged any heterogeneity above an I<sup>2</sup> value of 40% and a Chi<sup>2</sup> P value less than or equal to 0.05 to indicate moderate to substantial statistical heterogeneity (<a href="./references#CD013435-bbs2-0089" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). We did not conduct meta‐regression to explore heterogeneity in this updated review (see <a href="#CD013435-sec-0143">Differences between protocol and review</a>). </p> <p>As well as to looking at statistical results, we considered point estimates and overlap of CIs. If CIs overlap, then results are more consistent. However, combined studies may show a large consistent effect but with significant heterogeneity. We, therefore, planned to interpret heterogeneity with caution (<a href="./references#CD013435-bbs2-0095" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency. Journal of Clinical Epidemiology2011;64(12):1294‐302. [PUBMED: 21803546] ">Guyatt 2011a</a>). </p> </section> <section id="CD013435-sec-0069"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to source published protocols for each of our included studies by using clinical trials registers. We planned to compare published protocols with published study results, to assess the risk of selective reporting bias. In addition, we appraised reporting bias through visual assessment of funnel plots (<a href="./references#CD013435-bbs2-0091" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>). We planned to include figures of funnel plots in which we identified possible reporting bias from visual assessment; in this review, no reporting bias was found. </p> </section> <section id="CD013435-sec-0070"> <h4 class="title">Data synthesis</h4> <p>We presented a statistical summary of treatment effects in the absence of significant clinical or methodological heterogeneity. We used the statistical calculator in Review Manager 5 (RevMan 5) to perform meta‐analysis (<a href="./references#CD013435-bbs2-0107" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>For dichotomous outcomes, we used the Mantel‐Haenszel random‐effects model to account for potential variability in participant conditions between studies (<a href="./references#CD013435-bbs2-0083" title="BorensteinM , HedgesLV , HigginsJP , RothsteinHR . A basic introduction to fixed‐effect and random‐effects models for meta‐analysis. Research Synthesis Methods2010;1(2):97‐111. [PUBMED: 26061376] ">Borenstein 2010</a>). For continuous outcomes, we used inverse variance with a random‐effects model. </p> <p>We calculated CIs at 95% and used a P value less than or equal to 0.05 to judge whether a result was statistically significant; for statistically significant results, we also reported the number needed to treat for an additional beneficial outcome (NNTB). We considered imprecision in the results of analyses by assessing the CI around an effect measure; a wide CI would suggest a higher level of imprecision in our results. A small number of studies may also reduce precision (<a href="./references#CD013435-bbs2-0096" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines 6. Rating the quality of evidence ‐ imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. [PUBMED: 21839614] ">Guyatt 2011b</a>). </p> </section> <section id="CD013435-sec-0071"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In subgroup analysis, we evaluated the effect of the start of beta‐blocker therapy (i.e. before surgery, during surgery, or after surgery) and the type of beta‐blocking agent. In multi‐arm studies of more than one type of beta‐blocking agent, we compared each type of beta‐blocker using the halving method for the control group data (<a href="./references#CD013435-bbs2-0089" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>); thus, we avoided a unit of analysis error. </p> <p>We planned to complete subgroup analysis in which we found more than 10 studies (<a href="./references#CD013435-bbs2-0089" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), for the following outcomes. </p> <p> <ul id="CD013435-list-0007"> <li> <p>Early all‐cause mortality</p> </li> <li> <p>Acute myocardial infarction</p> </li> <li> <p>Cerebrovascular events</p> </li> <li> <p>Ventricular arrhythmias</p> </li> <li> <p>Atrial fibrillation</p> </li> <li> <p>Bradycardia</p> </li> <li> <p>Hypotension</p> </li> </ul> </p> </section> <section id="CD013435-sec-0072"> <h4 class="title">Sensitivity analysis</h4> <p>We explored the potential effect of decisions made as part of the review process. In each sensitivity analysis, we compared the effect estimate with the main analysis. We reported these effect estimates only if they indicated a difference in interpretation of the effect. We performed the following sensitivity analysis. </p> <p> <ul id="CD013435-list-0008"> <li> <p>We excluded studies in which the control group was standard care rather than placebo.</p> </li> <li> <p>We excluded studies that we judged at high or unclear risk of selection bias.</p> </li> <li> <p>We excluded studies that we judged to have high risk of attrition bias because of missing data with a loss of more than 10% participants, data that were unbalanced between groups, or that were unexplained. </p> </li> </ul> </p> <p>As well as sensitivity analyses performed in an earlier version of the review (<a href="./references#CD013435-bbs2-0116" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD004476.pub2] ">Blessberger 2014</a>), we also used sensitivity analysis to explore the potential effect of studies in which the control group were given beta‐blockers as rescue therapy. The review included several studies published before 2000, in which clinical management may differ from current standards. Accordingly, we made a post‐hoc decision to explore the potential effect of these early studies on the outcomes; in sensitivity analysis, we excluded studies published before 2000. </p> <p>We calculated RRs using a random‐effects model for all analyses in the review. Although the random‐effects model accounted for potential variation in the population, this statistical tool did not account for outcomes with rare events. In sensitivity analysis, we evaluated the effect of outcomes with events fewer than 1% using Peto odds ratio (<a href="./references#CD013435-bbs2-0089" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> <p>We assessed the effect of these potential biases on the following outcomes.</p> <p> <ul id="CD013435-list-0009"> <li> <p>Early all‐cause mortality</p> </li> <li> <p>Acute myocardial infarction</p> </li> <li> <p>Cerebrovascular events</p> </li> <li> <p>Ventricular arrhythmias</p> </li> <li> <p>Atrial fibrillation and flutter</p> </li> <li> <p>Bradycardia</p> </li> <li> <p>Hypotension</p> </li> </ul> </p> <section id="CD013435-sec-0073"> <h5 class="title">'Summary of findings' table and GRADE</h5> <p>One review author (SL) used the GRADE system to assess the certainty of the body of evidence and construct a 'Summary of findings' table associated with the following outcomes (<a href="./references#CD013435-bbs2-0094" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [PUBMED: 18436948] ">Guyatt 2008</a>). </p> <p> <ul id="CD013435-list-0010"> <li> <p>Early all‐cause mortality</p> </li> <li> <p>Acute myocardial infarction</p> </li> <li> <p>Cerebrovascular events</p> </li> <li> <p>Ventricular arrhythmias</p> </li> <li> <p>Atrial fibrillation and atrial flutter</p> </li> <li> <p>Bradycardia</p> </li> <li> <p>Hypotension</p> </li> </ul> </p> <p>The GRADE approach appraises the certainty of a body of evidence, based on the extent to which we can be confident that an estimate of effect or association reflects the item being assessed. Evaluation of the certainty of a body of evidence considers within‐study risk of bias, directness of the evidence, heterogeneity of the data, precision of the effect estimates, and risk of publication bias. We constructed a 'Summary of findings' table using <a href="./references#CD013435-bbs2-0093" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 28 June 2019. Hamilton (ON): McMaster University (developed by Evidence Prime). ">GRADEpro GDT</a>. </p> <p>We used the GRADE approach to appraise the certainty of the body of evidence for the remaining outcomes, but we did not construct a 'Summary of findings' table for these outcomes. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013435-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013435-sec-0074"></div> <section id="CD013435-sec-0075"> <h3 class="title">Description of studies</h3> <section id="CD013435-sec-0076"> <h4 class="title">Results of the search</h4> <p>After the removal of duplicates from the search results, we screened 5972 titles and abstracts, which included forward‐ and backward‐citation searches, clinical trials registers and grey literature. We sourced 37 full‐text reports to assess eligibility. <a href="#CD013435-fig-0001">Figure 1</a> </p> <div class="figure" id="CD013435-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram for updated search on 28 June 2019" data-id="CD013435-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for updated search on 28 June 2019</p> </div> </div> </div> </section> <section id="CD013435-sec-0077"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD013435-sec-0148" title="">Characteristics of included studies</a>. </p> <p>We included 63 studies with 7768 participants (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0028" title="LambRK , PrabhakarG , ThorpeJA , SmithS , NortonR , DydeJA . The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. European Heart Journal1988;9(1):32‐6. [PUBMED: 3257915] ">Lamb 1988</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0033" title="MaterneP , LarbuissonR , CollignonP , LimetR , KulbertusH . Prevention by acebutolol of rhythm disorders following coronary bypass surgery. International Journal of Cardiology1985;8(3):275‐83. [PUBMED: 3894250] ">Materne 1985</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0043" title="OrmerodOJ , McGregorCG , StoneDL , WisbeyC , PetchMC . Arrhythmias after coronary bypass surgery. British Heart Journal1984;51(6):618‐21. [PUBMED: 6610435] ">Ormerod 1984</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>; <a href="./references#CD013435-bbs2-0059" title="VechtRJ , NicolaidesEP , IkeukeJK , LiassidesC , ClearyJ , CooperWB . Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. International Journal of Cardiology1986;13(2):125‐34. [PUBMED: 3539826] ">Vecht 1986</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). Six studies were quasi‐randomized (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>); the remaining studies were RCTs. We included two studies for which we could only source the abstract and this limited the details of study characteristics that we were able to extract (<a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>). We sourced the full text of all remaining studies. </p> <p>This review includes ten new studies (<a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). The remaining studies were previously included in <a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>. </p> <section id="CD013435-sec-0078"> <h5 class="title">Study population</h5> <p>All participants were scheduled for cardiac surgery, which included coronary artery bypass graft (CABG) and valve replacement. </p> <p>We collected data from study reports on additional risk factors for included participants; we used information reported in the baseline characteristics tables and in the study inclusion and exclusion criteria. We summarized these factors in a table (<a href="./appendices#CD013435-sec-0135">Appendix 9</a>). </p> <p>Nine studies included only participants who were already taking beta‐blocking agents preoperatively (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>), whilst three studies excluded participants who were taking beta‐blockers preoperatively (<a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>). Other studies reported in baseline characteristics tables that at least some participants were taking beta‐blockers pre‐operatively; only 10 studies did not report preoperative beta‐blocker use (<a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0043" title="OrmerodOJ , McGregorCG , StoneDL , WisbeyC , PetchMC . Arrhythmias after coronary bypass surgery. British Heart Journal1984;51(6):618‐21. [PUBMED: 6610435] ">Ormerod 1984</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). </p> </section> <section id="CD013435-sec-0079"> <h5 class="title">Study setting</h5> <p>All studies were conducted in a hospital setting and four were multi‐centre studies (<a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>). </p> </section> <section id="CD013435-sec-0080"> <h5 class="title">Interventions and comparisons</h5> <p>Four studies were multi‐arm studies and included more than one type of beta‐blocker (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>) or different doses of the same beta‐blocker (<a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>). One study had two control groups according to time of withdrawal of existing propranolol treatment (<a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>). Types of beta‐blockers assessed were: </p> <p> <ul id="CD013435-list-0011"> <li> <p>propranolol versus a placebo (<a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>), or standard care (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0043" title="OrmerodOJ , McGregorCG , StoneDL , WisbeyC , PetchMC . Arrhythmias after coronary bypass surgery. British Heart Journal1984;51(6):618‐21. [PUBMED: 6610435] ">Ormerod 1984</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>); </p> </li> <li> <p>metoprolol versus a placebo (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>), or standard care (<a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>); </p> </li> <li> <p>sotalol versus a placebo (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>), or standard care (<a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>); </p> </li> <li> <p>esmolol versus a placebo (<a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>), or standard care (<a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>); </p> </li> <li> <p>landiolol versus a placebo (<a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>), or standard care (<a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>); </p> </li> <li> <p>acebutolol versus standard care (<a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0033" title="MaterneP , LarbuissonR , CollignonP , LimetR , KulbertusH . Prevention by acebutolol of rhythm disorders following coronary bypass surgery. International Journal of Cardiology1985;8(3):275‐83. [PUBMED: 3894250] ">Materne 1985</a>); </p> </li> <li> <p>timolol versus a placebo (<a href="./references#CD013435-bbs2-0059" title="VechtRJ , NicolaidesEP , IkeukeJK , LiassidesC , ClearyJ , CooperWB . Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. International Journal of Cardiology1986;13(2):125‐34. [PUBMED: 3539826] ">Vecht 1986</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>); </p> </li> <li> <p>carvedilol with a placebo (<a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>), or standard care (<a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>); </p> </li> <li> <p>nadolol with a placebo (<a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>); </p> </li> <li> <p>atenolol with a placebo (<a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>), or with standard care (<a href="./references#CD013435-bbs2-0028" title="LambRK , PrabhakarG , ThorpeJA , SmithS , NortonR , DydeJA . The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. European Heart Journal1988;9(1):32‐6. [PUBMED: 3257915] ">Lamb 1988</a>). </p> </li> </ul> </p> <p>In one study, the type of beta‐blocking agent was at the discretion of the treating clinician and included metoprolol, atenolol, sotalol, or inderal; these were compared with standard care (<a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>). </p> <p>In twelve studies, beta‐blockers were titrated according to heart rate or blood pressure (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>). In the remaining studies, beta‐blockers were given at a fixed dose. </p> <p>Duration of administration varied across studies. In nine studies, administration started before surgery (we defined this as any time up to 15 minutes before the surgery; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0028" title="LambRK , PrabhakarG , ThorpeJA , SmithS , NortonR , DydeJA . The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. European Heart Journal1988;9(1):32‐6. [PUBMED: 3257915] ">Lamb 1988</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). In twenty studies, administration started during surgery (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>). In the remaining studies, administration started after surgery. </p> </section> <section id="CD013435-sec-0081"> <h5 class="title">Outcomes</h5> <p>All studies included at least one review outcome, as this formed part of the inclusion criteria for this review. We reported numbers of studies for each outcome in <a href="#CD013435-sec-0092">Effects of interventions</a>. </p> </section> <section id="CD013435-sec-0082"> <h5 class="title">Funding</h5> <p>We found that most studies did not report sources of support or conflicts of interest. Eight studies reported support from pharmaceutical companies (<a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0059" title="VechtRJ , NicolaidesEP , IkeukeJK , LiassidesC , ClearyJ , CooperWB . Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. International Journal of Cardiology1986;13(2):125‐34. [PUBMED: 3539826] ">Vecht 1986</a>), and nine studies reported departmental or other sources of funding, which we assumed to be independent (<a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>). One study declared support from both pharmaceutical and independent sources (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>). </p> </section> </section> <section id="CD013435-sec-0083"> <h4 class="title">Excluded studies</h4> <p>We excluded 21 studies following assessment of full texts (<a href="#CD013435-fig-0001">Figure 1</a>). </p> <p>We reported the details of 12 of these excluded studies (<a href="./references#CD013435-bbs2-0064" title="DeBruijnNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beta‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66(2):137‐41. [PUBMED: 2880530] ">De Bruijn 1987</a>; <a href="./references#CD013435-bbs2-0065" title="DengYK , WeiF , LiZL , ZhangDG , YangSY . Esmolol protects the myocardium and facilitates direct version intracardiac operation with a beating heart. Circulation Journal2002;66(8):715‐7. [PUBMED: 12197593] ">Deng 2002</a>; <a href="./references#CD013435-bbs2-0066" title="EfeEM , BilginBA , AlanogluZ , AkbabaM , DenkerC . Comparison of bolus and continuous infusion of esmolol on hemodynamic response to laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft. Brazilian Journal of Anesthesiology2014;64(4):247‐52. [PUBMED: 24998108] ">Efe 2014</a>; <a href="./references#CD013435-bbs2-0067" title="FujiiM , BesshoR , OchiM , ShimizuK , TerajimaK , TakedaS . Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. Journal of Cardiovascular Surgery2012;53(3):369‐74. [CN‐00881488; PUBMED: 22249647] ">Fujii 2012</a>; <a href="./references#CD013435-bbs2-0068" title="HamaguchiS , NagaoM , TakahashiY , IkedaT , YamaguchiS . Low dose landiolol combined with catecholamine can decrease heart rate without suppression of cardiac contraction after cardiopulmonary bypass. Dokkyo Journal of Medical Sciences2014;41(1):27‐33. [373250136] ">Hamaguchi 2014</a>; <a href="./references#CD013435-bbs2-0069" title="ImrenY , BensonAA , ZorH , TasogluI , ErerenE , SinciV . Preoperative beta‐blocker use reduces atrial fibrillation in off‐pump coronary bypass surgery. Australian and New Zealand Journal of Surgery2007;77(6):429‐32. [CN‐00866547; PUBMED: 17501880] ">Imren 2007</a>; <a href="./references#CD013435-bbs2-0070" title="NewsomeLR , RothJV , HugCC , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65(5):451‐6. [PUBMED: 3485937] ">Newsome 1986</a>; <a href="./references#CD013435-bbs2-0071" title="O'DwyerJP , YorukogluD , HarrisMN . The use of esmolol to attenuate the haemodynamic response when extubating patients following cardiac surgery ‐ a double‐blind controlled study. European Heart Journal1993;14(5):701‐4. [PUBMED: 8099549] ">O'Dwyer 1993</a>; <a href="./references#CD013435-bbs2-0072" title="ReesC , SultaniZ , TheologouT , PoonS , FieldLM , KuduvalliM , et al. Prophylactic treatment of atrial fibrillation post coronary artery bypass grafting. A randomised controlled trial of sotalol and magnesium versus placebo. European Surgical Research2015;1:89. [71958303] ">Rees 2015</a>; <a href="./references#CD013435-bbs2-0073" title="SezaiA , OsakaS , YaoitaH , IshiiY , ArimotoM , HataH , et al. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: prevention of atrial fibrillation after cardiac surgery with landiolol hydrochloride for left ventricular dysfunction (PLATON) trial. Journal of Thoracic and Cardiovascular Surgery2015;150(4):957‐64. [PUBMED: 26254752] ">Sezai 2015</a>; <a href="./references#CD013435-bbs2-0074" title="TempeDK , MulchandaniP , TandonMS , MehtaN , TomarAS , BanerjeeA , et al. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. Indian Heart Journal1999;51(3):294‐300. [PUBMED: 10624069] ">Tempe 1999</a>; <a href="./references#CD013435-bbs2-0075" title="YaziciogluH , OzgokA , BalabanF , DoganayB , UnverS . Single dose esmolol attenuates bispectral index scale response to intubation during fentanyl‐midazolam anesthesia for cardiac surgery. Turkish Journal of Thoracic and Cardiovascular Surgery2012;20(1):72‐8. [DOI: 10.5606/tgkdc.dergisi.2012.012; WOS:000299866900012] ">Yazicioglu 2012</a>). Seven of these 12 studies did not measure or report outcomes relevant to the review (<a href="./references#CD013435-bbs2-0064" title="DeBruijnNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beta‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66(2):137‐41. [PUBMED: 2880530] ">De Bruijn 1987</a>; <a href="./references#CD013435-bbs2-0065" title="DengYK , WeiF , LiZL , ZhangDG , YangSY . Esmolol protects the myocardium and facilitates direct version intracardiac operation with a beating heart. Circulation Journal2002;66(8):715‐7. [PUBMED: 12197593] ">Deng 2002</a>; <a href="./references#CD013435-bbs2-0066" title="EfeEM , BilginBA , AlanogluZ , AkbabaM , DenkerC . Comparison of bolus and continuous infusion of esmolol on hemodynamic response to laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft. Brazilian Journal of Anesthesiology2014;64(4):247‐52. [PUBMED: 24998108] ">Efe 2014</a>; <a href="./references#CD013435-bbs2-0070" title="NewsomeLR , RothJV , HugCC , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65(5):451‐6. [PUBMED: 3485937] ">Newsome 1986</a>; <a href="./references#CD013435-bbs2-0071" title="O'DwyerJP , YorukogluD , HarrisMN . The use of esmolol to attenuate the haemodynamic response when extubating patients following cardiac surgery ‐ a double‐blind controlled study. European Heart Journal1993;14(5):701‐4. [PUBMED: 8099549] ">O'Dwyer 1993</a>; <a href="./references#CD013435-bbs2-0074" title="TempeDK , MulchandaniP , TandonMS , MehtaN , TomarAS , BanerjeeA , et al. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. Indian Heart Journal1999;51(3):294‐300. [PUBMED: 10624069] ">Tempe 1999</a>; <a href="./references#CD013435-bbs2-0075" title="YaziciogluH , OzgokA , BalabanF , DoganayB , UnverS . Single dose esmolol attenuates bispectral index scale response to intubation during fentanyl‐midazolam anesthesia for cardiac surgery. Turkish Journal of Thoracic and Cardiovascular Surgery2012;20(1):72‐8. [DOI: 10.5606/tgkdc.dergisi.2012.012; WOS:000299866900012] ">Yazicioglu 2012</a>). We excluded one study in which all participants in the intervention group were also given magnesium (<a href="./references#CD013435-bbs2-0072" title="ReesC , SultaniZ , TheologouT , PoonS , FieldLM , KuduvalliM , et al. Prophylactic treatment of atrial fibrillation post coronary artery bypass grafting. A randomised controlled trial of sotalol and magnesium versus placebo. European Surgical Research2015;1:89. [71958303] ">Rees 2015</a>), and three studies in which all participants, including those in the control groups, were given beta‐blockers (<a href="./references#CD013435-bbs2-0067" title="FujiiM , BesshoR , OchiM , ShimizuK , TerajimaK , TakedaS . Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. Journal of Cardiovascular Surgery2012;53(3):369‐74. [CN‐00881488; PUBMED: 22249647] ">Fujii 2012</a>; <a href="./references#CD013435-bbs2-0069" title="ImrenY , BensonAA , ZorH , TasogluI , ErerenE , SinciV . Preoperative beta‐blocker use reduces atrial fibrillation in off‐pump coronary bypass surgery. Australian and New Zealand Journal of Surgery2007;77(6):429‐32. [CN‐00866547; PUBMED: 17501880] ">Imren 2007</a>; <a href="./references#CD013435-bbs2-0073" title="SezaiA , OsakaS , YaoitaH , IshiiY , ArimotoM , HataH , et al. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: prevention of atrial fibrillation after cardiac surgery with landiolol hydrochloride for left ventricular dysfunction (PLATON) trial. Journal of Thoracic and Cardiovascular Surgery2015;150(4):957‐64. [PUBMED: 26254752] ">Sezai 2015</a>). In one study all participants in both groups were given catecholamines but those in the control group were given a lower dose and thus we considered the catecholamine to be control group variable that could influence the result (<a href="./references#CD013435-bbs2-0068" title="HamaguchiS , NagaoM , TakahashiY , IkedaT , YamaguchiS . Low dose landiolol combined with catecholamine can decrease heart rate without suppression of cardiac contraction after cardiopulmonary bypass. Dokkyo Journal of Medical Sciences2014;41(1):27‐33. [373250136] ">Hamaguchi 2014</a>). See <a href="./references#CD013435-sec-0149" title="">Characteristics of excluded studies</a>. </p> <p>This review does not include studies that were previously excluded; details of previous exclusions can be found elsewhere (<a href="./references#CD013435-bbs2-0116" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD004476.pub2] ">Blessberger 2014</a>; <a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). </p> <section id="CD013435-sec-0084"> <h5 class="title">Studies awaiting classification</h5> <p>We found four studies awaiting classification (<a href="./references#CD013435-bbs2-0076" title="BozotlanO , GultekinY , MeseB , ErdemK , ErotluE , YasimA . The effect of esmolol on prevention of postoperative atrial fibrillation after coronary artery bypass graft surgery. International Journal of Cardiology2013;1:S142. [71039415] ">Bozotlan 2013</a>; <a href="./references#CD013435-bbs2-0077" title="IshigakiD , ArimotoT , IwayamaT , YashiroY , KutsuzawaD , TamuraH , et al. Landiolol, an ultra‐short‐acting beta‐blocker, for prevention of atrial fibrillation after catheter ablation. European Heart Journal2012;33(Suppl 1):352. ">Ishigaki 2012</a>; <a href="./references#CD013435-bbs2-0078" title="NCT00959569 . Esmolol in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00959569 (first received 14 August 2009). ">NCT00959569</a>; <a href="./references#CD013435-bbs2-0079" title="PACTR201801003026226 . Cardiac recovery after single, low esmolol dose in patients undergoing valve replacement surgery. A randomized controlled double‐blind study. apps.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201801003026226 (first received 28 January 2018). ">PACTR201801003026226</a>). Two were published only as abstracts with insufficient information to assess eligibility or extract outcome data (<a href="./references#CD013435-bbs2-0076" title="BozotlanO , GultekinY , MeseB , ErdemK , ErotluE , YasimA . The effect of esmolol on prevention of postoperative atrial fibrillation after coronary artery bypass graft surgery. International Journal of Cardiology2013;1:S142. [71039415] ">Bozotlan 2013</a>; <a href="./references#CD013435-bbs2-0077" title="IshigakiD , ArimotoT , IwayamaT , YashiroY , KutsuzawaD , TamuraH , et al. Landiolol, an ultra‐short‐acting beta‐blocker, for prevention of atrial fibrillation after catheter ablation. European Heart Journal2012;33(Suppl 1):352. ">Ishigaki 2012</a>), and two were described as completed on a clinical trials register but results are not yet published (<a href="./references#CD013435-bbs2-0078" title="NCT00959569 . Esmolol in cardiac surgery. clinicaltrials.gov/ct2/show/NCT00959569 (first received 14 August 2009). ">NCT00959569</a>; <a href="./references#CD013435-bbs2-0079" title="PACTR201801003026226 . Cardiac recovery after single, low esmolol dose in patients undergoing valve replacement surgery. A randomized controlled double‐blind study. apps.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201801003026226 (first received 28 January 2018). ">PACTR201801003026226</a>). See <a href="./references#CD013435-sec-0150" title="">Characteristics of studies awaiting classification</a>. </p> </section> <section id="CD013435-sec-0085"> <h5 class="title">Ongoing studies</h5> <p>We found two ongoing studies; one compared landiolol versus standard care with an expected recruitment of 60 participants (<a href="./references#CD013435-bbs2-0081" title="UMIN000004216 . Efficacy of beta‐blocker on the autonomic nervous activities and the onset of atrial fibrillation or flutter in patients after cardiac surgery. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000005063 (first received 1 October 2010). ">UMIN000004216</a>), and one compared esmolol to a placebo, with an expected recruitment of 144 participants (<a href="./references#CD013435-bbs2-0080" title="Chictr‐ior‐16009203 . Perioperative esmolol injection and acute kidney injury associated with CPB after cardiac surgery. www.chictr.org.cn/showproj.aspx?proj=15579 (first received 13 August 2016). ">Chictr‐ior‐16009203</a>). See <a href="./references#CD013435-sec-0151" title="">Characteristics of ongoing studies</a>. </p> </section> </section> </section> <section id="CD013435-sec-0086"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD013435-sec-0148" title="">Characteristics of included studies</a>, <a href="#CD013435-fig-0002">Figure 2</a> and <a href="#CD013435-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD013435-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD013435-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD013435-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD013435-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <p>Overall, we judged 68% studies to be at high risk of bias in at least one domain.</p> <section id="CD013435-sec-0087"> <h4 class="title">Allocation</h4> <p>For random sequence generation, we found that few studies reported sufficient methods used to randomize participants, and we judged only nine studies to be at low risk of selection bias (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>). </p> <p>We judged six quasi‐randomized studies to be at high risk of selection bias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>). One study described randomization as being open, and another study used a method of coin‐tossing but we were not confident that this method had been used as described because the number of participants in each group was equal; we judged both studies to be at high risk of selection bias (<a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>). We judged the remaining studies to have an unclear risk of selection bias for random sequence generation. </p> <p>For allocation concealment, we judged only seven to be at low risk of bias (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>). We judged the quasi‐randomized studies to be at high risk of bias for allocation concealment, and we judged the remaining studies to have an unclear risk of bias because of inadequate reporting of methods to conceal allocation. </p> </section> <section id="CD013435-sec-0088"> <h4 class="title">Blinding</h4> <p>Many of the studies in this review compared a beta‐blocker with standard care, and because it was not feasible to blind personnel to the intervention, we judged all studies with a standard care control group to be at high risk of performance bias because of this open‐label study design. In addition, we judged <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a> to be at high risk of performance bias because personnel were aware of the use of bisoprolol in one of the study arms. </p> <p>We found insufficient information to confirm blinding of personnel in only seven studies (<a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>); we judged these to have an unclear risk of performance bias. We assumed that studies described as double‐blinded had used appropriate methods to blind personnel to study treatments, and similarly if the comparison was described as a placebo agent, we also assumed that this was blinded, and we judged these remaining studies to be at low risk of performance bias. </p> <p>Only seven studies reported that outcome assessors were blinded and we judged these studies to be at low risk of detection bias (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). Twenty‐two studies did not report whether outcome assessors were blinded and we judged detection bias to be unclear (<a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>; <a href="./references#CD013435-bbs2-0059" title="VechtRJ , NicolaidesEP , IkeukeJK , LiassidesC , ClearyJ , CooperWB . Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. International Journal of Cardiology1986;13(2):125‐34. [PUBMED: 3539826] ">Vecht 1986</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). Because the remaining open‐label studies did not describe the blinding of outcome assessors, we assumed that blinding had not occurred and, therefore, judged these to be at high risk of detection bias. </p> </section> <section id="CD013435-sec-0089"> <h4 class="title">Incomplete outcome data</h4> <p>Most studies did not report losses, and we assumed that these studies had no losses; in these studies we used the numbers of randomized participants to inform the assumed number of analysed participants. In addition, most studies did not report whether investigators used intention‐to‐treat analysis. When studies reported losses but did not state whether investigators had used intention‐to‐treat analysis, we assumed the use of per‐protocol analysis. We reported this information in the <a href="./references#CD013435-sec-0148" title="">Characteristics of included studies</a>. </p> <p>We judged 10 studies to be at high risk of attrition bias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>); these studies lost more than 10% of participants, loss of participants was imbalanced between groups, or exclusions were unclearly reported. </p> <p>We judged the remaining studies to be at low risk of attrition bias because study authors reported no losses or losses were fewer than 10% and we did not expect the loss to influence outcome data. In the event that study authors did not report whether all participants were included in the outcomes, we assumed that there were no losses. </p> </section> <section id="CD013435-sec-0090"> <h4 class="title">Selective reporting</h4> <p>No studies were prospectively registered with clinical trials registers and this limited our ability to effectively assess the risk of reporting bias. Two studies provided clinical trial registration numbers but the time point of registration was unclear (<a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). We assessed one of these studies to be at high risk of reporting bias because we noted that additional outcomes were reported that were not included in the clinical trials register documents (<a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>). We assessed <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a> to be at unclear risk of reporting bias, because we could not be certain whether registration was retrospective. </p> <p>We judged risk of selective reporting to be high in three studies; two studies reported statistically significant results only (<a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>), and in another study, we noted that study group allocation of participants with certain adverse events (acute myocardial infarction, stroke) remained unclear and we considered this to be evidence of selective under‐reporting (<a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>). </p> <p>We judged the remaining studies to be at unclear risk of reporting bias.</p> </section> <section id="CD013435-sec-0091"> <h4 class="title">Other potential sources of bias</h4> <p>Eleven studies reported the use of beta‐blockers as rescue therapy in the control group (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>). We believed that this introduced considerable bias to the data and we judged all these studies to be at high risk of bias. In addition, we judged <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a> to be at high risk of bias because more participants in the control group were taking beta‐blockers before entry into the study. </p> <p>Three studies were reported only as abstracts and these short reports were insufficient to judge risks of other bias, and as such, we judged these to be unclear (<a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>). Similarly, three studies had limited information in the report and it was also not feasible to assess risks of other bias in these studies (<a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>). In <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>, we noted a difference in the number of participants taking beta‐blockers preoperatively and we were uncertain of this effect on the data. We did not identify any other sources of bias in the remaining study reports. </p> </section> </section> <section id="CD013435-sec-0092"> <h3 class="title" id="CD013435-sec-0092">Effects of interventions</h3> <p>See: <a href="./full#CD013435-tbl-0001"><b>Summary of findings for the main comparison</b> Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery</a> </p> <section id="CD013435-sec-0093"> <h4 class="title">Early all‐cause mortality</h4> <p>Twenty‐nine studies reported mortality data (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). We noted that 12 of these studies had no deaths in either group (<a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0023" title="IveyMF , IveyTD , BaileyWW , WilliamsDB , HesselEA , MillerDW . Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery1983;85(2):214‐8. [PUBMED: 6337306] ">Ivey 1983</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>). </p> <p>We found that studies reported few events, and beta‐blockers probably make little or no difference to all‐cause mortality at 30 days (RR 0.95, 95% CI 0.47 to 1.90; I<sup>2</sup> = 0%; 4099 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0006" title="">Analysis 1.1</a>). We used GRADE to downgrade the certainty of the evidence by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain; and one level for imprecision owing to the wide CI and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a> and <a href="#CD013435-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD013435-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.1 All‐cause mortality (30 days)" data-id="CD013435-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.1 All‐cause mortality (30 days) </p> </div> </div> </div> </section> <section id="CD013435-sec-0094"> <h4 class="title">Long‐term mortality</h4> <p>Three studies reported mortality at one year (<a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>), at six months (<a href="./references#CD013435-bbs2-0017" title="GandhiPS , GoyalRK , JainAR , MallyaBS , GuptaVM , ShahDS , et al. Beneficial effects of carvedilol as a concomitant therapy to angiotensin‐converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. Canadian Journal of Physiology and Pharmacology2007;85(2):193‐9. [PUBMED: 17487260] ">Gandhi 2007</a>), and at seven months (<a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>). We found little or no difference in effect between groups (RR 0.90, 95% CI 0.29 to 2.79; I<sup>2</sup> = 0%; 511 participants; very low‐certainty evidence; <a href="./references#CD013435-fig-0007" title="">Analysis 1.2</a>). We used GRADE to downgrade the certainty of the evidence by three levels: one level for study limitations because one of the three studies was at high risk of bias in two domains; and two levels for imprecision owing to the wide CI and because the evidence was from only three studies with few participants. </p> </section> <section id="CD013435-sec-0095"> <h4 class="title">Death due to cardiac causes</h4> <p>Four studies reported death due to cardiac causes (<a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>), with little or no difference in effect between groups (RR 0.84, 95% CI 0.14 to 5.19; I<sup>2</sup> = 0%; 320 participants; very low‐certainty evidence; <a href="./references#CD013435-fig-0008" title="">Analysis 1.3</a>). <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a> reported no events in either group. We used GRADE to downgrade the certainty of the evidence by three levels: one level for study limitations because most of the studies were at high risk of bias in at least one domain, and two levels of imprecision owing to the wide CI and because the evidence was from few studies with few participants. </p> </section> <section id="CD013435-sec-0096"> <h4 class="title">Acute myocardial infarction</h4> <p>Twenty‐five studies reported participants who had a myocardial infarction during the perioperative period or within 30 days of surgery (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0039" title="NicolsonSC , JobesDR , QuinlanJJ . Cardiovascular effects of esmolol in patients anesthetized with sufentanil‐pancuronium for myocardial revascularization. Journal of Cardiothoracic Anesthesia1990;5(Suppl 2):55‐8. ">Nicolson 1990</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>). We noted no events in three of these studies (<a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>). </p> <p>We found little or no difference in the number of people having a myocardial infarction when beta‐blockers were used (RR 1.05, 95% CI 0.72 to 1.52; I<sup>2</sup> = 0%: 3946 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0009" title="">Analysis 1.4</a>). We used GRADE to downgrade the certainty of the evidence by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain; and one level for imprecision owing to the wide confidence interval in the effect estimate and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013435-sec-0097"> <h4 class="title">Cerebrovascular events</h4> <p>Seven studies reported the number of participants who had a cerebrovascular event (<a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>). We did not include data for <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a> in the analysis because study authors did not report to which group two participants with cerebrovascular events belonged. We did not include data for <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>, in which one participant in the control group had a stroke, because this event was reported as fatal by study authors. </p> <p>Beta‐blockers may make little or no difference to cerebrovascular events, however, few studies reported events; seven out of 704 participants experienced an event in the control group compared to 10 out of 767 participants who experienced an event when beta‐blockers were used (RR 1.37, 95% CI 0.51 to 3.67; I<sup>2</sup> = 0%; 5 studies, 1471 participants; very low‐certainty evidence; <a href="./references#CD013435-fig-0010" title="">Analysis 1.5</a>). We used GRADE to downgrade the certainty of the evidence by three levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and two levels for imprecision owing to the very wide CI and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013435-sec-0098"> <h4 class="title">Ventricular arrhythmias</h4> <p>Thirteen studies reported ventricular arrhythmias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0022" title="HarrisonL , RalleyFE , WynandsE , RobbinsGR , SamiM , RipleyR , et al. The role of an ultra short‐acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology1987;66(4):413‐8. [PUBMED: 2881505] ">Harrison 1987</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>). We did not include one study in meta‐analysis because we could not be certain whether events were recorded in the control group (<a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>). </p> <p>In meta‐analysis of the remaining studies, we found that beta‐blockers probably reduce episodes of ventricular arrhythmias (RR 0.40, 95% CI 0.25 to 0.63; I<sup>2</sup> = 0%; 12 studies, 2296 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0011" title="">Analysis 1.6</a>). In absolute terms, we found 32 fewer episodes per 1000 when beta‐blockers were used, based on a control risk of 54 per 1000; the number needed to treat for a beneficial outcomes (NNTB) was 31 (95% CI 25 to 50). We used GRADE to downgrade the certainty of the evidence by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias, and one level for imprecision because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013435-sec-0099"> <h4 class="title">Atrial fibrillation or flutter, or both</h4> <p>Forty studies reported atrial fibrillation or atrial flutter (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0014" title="DyJ , JayasunderaT , KapadalaD , CupermanC , WhitmanG , DiSesaV , et al. Post‐operative atrial fibrillation—a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology1998;31(Suppl A):324A. ">Dy 1998</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0020" title="GrahamSP , HasnainS , CelanoJ . Low dose but not medium dose beta blockers reduce post‐operative atrial fibrillation. Circulation1996;94(8 Suppl 1):190‐1. ">Graham 1996</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0028" title="LambRK , PrabhakarG , ThorpeJA , SmithS , NortonR , DydeJA . The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. European Heart Journal1988;9(1):32‐6. [PUBMED: 3257915] ">Lamb 1988</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0033" title="MaterneP , LarbuissonR , CollignonP , LimetR , KulbertusH . Prevention by acebutolol of rhythm disorders following coronary bypass surgery. International Journal of Cardiology1985;8(3):275‐83. [PUBMED: 3894250] ">Materne 1985</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0043" title="OrmerodOJ , McGregorCG , StoneDL , WisbeyC , PetchMC . Arrhythmias after coronary bypass surgery. British Heart Journal1984;51(6):618‐21. [PUBMED: 6610435] ">Ormerod 1984</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>; <a href="./references#CD013435-bbs2-0045" title="PaullDL , TidwellSL , GuytonSW , HarveyE , WoolfRA , HolmesJR , et al. Beta‐blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery1997;173(5):419‐21. [PUBMED: 9168080] ">Paull 1997</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>; <a href="./references#CD013435-bbs2-0059" title="VechtRJ , NicolaidesEP , IkeukeJK , LiassidesC , ClearyJ , CooperWB . Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. International Journal of Cardiology1986;13(2):125‐34. [PUBMED: 3539826] ">Vecht 1986</a>; <a href="./references#CD013435-bbs2-0061" title="WhiteHD , AntmanEM , GlynnMA , CollinsJJ , CohnLH , SheminRJ , et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation1984;70(3):479‐84. [PUBMED: 6378423] ">White 1984</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). </p> <p>We found that beta‐blockers reduce the number of participants who experience atrial fibrillation or atrial flutter (RR 0.50, 95% CI 0.42 to 0.59; I<sup>2</sup> = 51%; 5650 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0012" title="">Analysis 1.7</a>). In absolute terms, we found 163 fewer incidences per 1000 when beta‐blockers were used, based on a control risk of 327 per 1000; the NNTB was 6 (95% CI 5 to 7). We used GRADE to downgrade the certainty of the evidence by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias, and one level for inconsistency owing to a moderate level of statistical heterogeneity which we were unable to explain through subgroup analysis. See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a> and <a href="#CD013435-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD013435-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.7 Atrial fibrillation or flutter, or both" data-id="CD013435-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.7 Atrial fibrillation or flutter, or both </p> </div> </div> </div> </section> <section id="CD013435-sec-0100"> <h4 class="title">Bradycardia</h4> <p>Twenty‐three studies reported bradycardia (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>). However, data for bradycardia were not clearly reported in 11 studies and we were uncertain whether some of these study authors had collected data for bradycardia in the control group (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0018" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65(2):157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>). Therefore, we did not include these studies in meta‐analysis; for these studies, we have reported data for bradycardia, as presented by study authors, in <a href="./references#CD013435-sec-0148" title="">Characteristics of included studies</a>. </p> <p>In analysis of the remaining studies, we found no evidence of a difference in bradycardia when beta‐blockers were used (RR 1.63, 95% CI 0.92 to 2.91; I<sup>2</sup> = 16%; 12 studies; 1640 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0013" title="">Analysis 1.8</a>). We used the GRADE approach to downgrade the certainty of the evidence by two levels: one for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain, and one level for imprecision owing to the very wide confidence interval and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013435-sec-0101"> <h4 class="title">Hypotension</h4> <p>Nineteen studies reported hypotension (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0058" title="SuttorpMJ , KingmaJH , PeelsHO , KoomenEM , TijssenJG , VanHemelNM , et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology1991;68(11):1163‐9. [PUBMED: 1951075] ">Suttorp 1991</a>). However, nine studies did not clearly report data for hypotension and we were uncertain whether study authors had collected data for hypotension in the control group (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0003" title="ArarC , ColakA , AlagolA , UzerSS , EgeT , TuranN , et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. European Journal of Anaesthesiology2007;24(10):826‐31. [PUBMED: 17583595] ">Arar 2007</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0027" title="KurianSM , EvansR , FernandesNO , SherryKM . The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia2001;56(12):1163‐8. [PUBMED: 11736772] ">Kurian 2001</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0038" title="NeusteinSM , BronheimDS , LaskerS , ReichDL , ThysDM . Esmolol and intraoperative myocardial ischemia: a double‐blind study. Journal of Cardiothoracic and Vascular Anesthesia1994;8(3):273‐7. [PUBMED: 7914754] ">Neustein 1994</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0047" title="RevesJG , CroughwellND , HawkinsE , SmithLR , JacobsJR , RankinS , et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery1990;100(2):221‐7. [PUBMED: 1974664] ">Reves 1990</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>). Therefore, we did not include these studies in meta‐analysis; for these studies, we have reported data for hypotension, as presented by study authors, in <a href="./references#CD013435-sec-0148" title="">Characteristics of included studies</a>. </p> <p>In analysis of the remaining studies, we found no evidence of a difference in hypotension when beta‐blockers were used (RR 1.84, 95% CI 0.89 to 3.80; I<sup>2</sup> = 0%; 10 studies, 1538 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0014" title="">Analysis 1.9</a>). We used GRADE to downgrade the certainty of the evidence by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain, and one level owing to the very wide confidence interval and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). See <a href="./full#CD013435-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013435-sec-0102"> <h4 class="title">Congestive heart failure</h4> <p>Three studies reported congestive heart failure (<a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). We found little or no difference between groups in the number of participants who had heart failure (RR 0.22, 95% CI 0.04 to 1.36; I<sup>2</sup> = 0%; 331 participants; very low‐certainty evidence; <a href="./references#CD013435-fig-0015" title="">Analysis 1.10</a>). We used GRADE to downgrade the certainty of the evidence by three levels; one level for study limitations because two of the three studies were at high risk of bias in at least one domain, and two levels for imprecision because the evidence was from few studies with few participants. </p> </section> <section id="CD013435-sec-0103"> <h4 class="title">Length of hospital stay</h4> <p>Eighteen studies reported length of hospital stay (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0008" title="BoothJV , WardEE , ColganKC , FunkBL , El‐MoalemH , SmithMP , et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute β‐adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia2004;98(5):1224‐31. [PUBMED: 15105192] ">Booth 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0011" title="CorkRC , KramerTH , DreischmeierB , BehrS , DiNardoJA . The effect of esmolol given during cardiopulmonary bypass. Anesthesia and Analgesia1995;80(1):28‐40. [PUBMED: 7802296] ">Cork 1995</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0019" title="GomesJA , IpJ , Santoni‐RugiuF , MehtaD , ErginA , LansmanS , et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double‐blind, placebo‐controlled study. Journal of the American College of Cardiology1999;34(2):334‐9. [PUBMED: 10440141] ">Gomes 1999</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>). We did not include data from four studies in meta‐analysis because the data were not reported in equivalent values (mean and standard deviation; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>). </p> <p>In meta‐analysis of remaining studies, we found that length of stay was shorter when participants were treated with beta‐blockers (MD −0.54 days, 95% CI −0.90 to −0.19; I<sup>2</sup> = 58%; 14 studies, 2450 participants; low‐certainty evidence; <a href="./references#CD013435-fig-0016" title="">Analysis 1.11</a>). We used GRADE to downgrade the certainty of the evidence by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain, and one level for inconsistency owing to a moderate level of statistical heterogeneity. We did not explore possible causes of this heterogeneity through formal subgroup analysis. </p> </section> <section id="CD013435-sec-0104"> <h4 class="title">Quality of life</h4> <p>No studies reported outcome data for quality of life.</p> </section> <section id="CD013435-sec-0105"> <h4 class="title">Subgroup analysis</h4> <p>We did not complete subgroup analysis for cerebrovascular events, because we found fewer than 10 studies for this outcome. </p> <section id="CD013435-sec-0106"> <h5 class="title">Type of beta‐blocker</h5> <p>We did not include <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a> in subgroup analysis by type of beta‐blocker because participants in the intervention group were given a variety of types of beta‐blockers and study authors did not report data according to type of beta‐blocker. For subgroup analysis of <a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a> and <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>, in which both studies had two beta‐blocker groups, we halved the control group data. </p> <p> <ul id="CD013435-list-0012"> <li> <p>Early all‐cause mortality: we found no evidence of difference between subgroups (P = 0.74, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0017" title="">Analysis 2.1</a>). Each type of agent showed little or no difference in all‐cause mortality, which was consistent with our primary analysis: metoprolol (RR 1.72, 95% CI 0.44 to 6.69; I<sup>2</sup> = 0%; 7 studies, 1627 participants); propranolol (RR 0.67, 95% CI 0.19 to 2.37; I<sup>2</sup> = 0%; 9 studies, 809 participants); sotalol (RR 0.65, 95% CI 0.08 to 5.25; I<sup>2</sup> = 0%; 8 studies, 1037 participants); esmolol (RR 2.65, 95% CI 0.12 to 60.21; 2 studies, 54 participants); timolol (RR 2.86, 95% CI 0.12 to 66.44; 1 study, 41 participants); landiolol (RR 0.33, 95% CI 0.04 to 2.53; I<sup>2</sup> = 0%; 2 studies, 241 participants); and atenolol (RR 3.00, 95% CI 0.13 to 71.51; 1 study, 80 participants). </p> </li> <li> <p>Acute myocardial infarction: we found no evidence of a difference between subgroups (P = 0.57, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0018" title="">Analysis 2.2</a>). Each type of agent showed little or no difference in myocardial infarction, which was consistent with our primary analysis: metoprolol (RR 2.00, 95% CI 0.91 to 4.40; I<sup>2</sup> = 0%; 2 studies, 1200 participants); propranolol (RR 0.76, 95% CI 0.43 to 1.32; I<sup>2</sup> = 0%; 11 studies, 1088 participants); sotalol (RR 0.59, 95% CI 0.07 to 4.70; I<sup>2</sup> = 0%; 4 studies, 643 participants); esmolol (RR 0.28, 95% CI 0.01 to 6.33; 2 studies, 69 participants); nadolol (RR 0.37, 95% CI 0.02 to 8.87; 1 study, 141 participants); landiolol (RR 2.57, 95% CI 0.13 to 52.15; 1 study, 101 participants); acebutolol (RR 1.00, 95% CI 0.06 to 15.55; 1 study, 100 participants); and atenolol (RR 1.33, 95% CI 0.32 to 5.53; 1 study, 70 participants). </p> </li> <li> <p>Ventricular arrhythmias: we found no evidence of a difference between subgroups (P = 0.20, I<sup>2</sup> = 36.0%; <a href="./references#CD013435-fig-0019" title="">Analysis 2.3</a>). Studies of metoprolol showed little or no difference between groups in ventricular arrhythmias (RR 0.26, 95% CI 0.06 to 1.06; I<sup>2</sup> = 0%; 2 studies, 1094 participants), and, similarly, we found little or no difference between groups for sotalol (RR 2.38, 95% CI 0.40 to 14.27; I<sup>2</sup> = 0%; 3 studies, 452 participants). Analysis of the remaining studies according to type of beta‐blocker showed findings consistent with the primary analysis: propranolol (RR 0.41, 95% CI 0.21 to 0.79; I<sup>2</sup> = 0%; 5 studies, 592 participants); and esmolol (RR 0.26, 95% CI 0.08 to 0.84; I<sup>2</sup> = 32%; 2 studies, 88 participants). Only one study reported data for atenolol, in which study authors reported no events (<a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>). </p> </li> <li> <p>Atrial fibrillation or flutter, or both: we found differences in incidences of atrial fibrillation according to the type of beta‐blocker that participants were given (P &lt; 0.0001, I<sup>2</sup> = 76.6%; <a href="./references#CD013435-fig-0020" title="">Analysis 2.4</a>). However, types of agents that demonstrated an effect that differed from the primary analysis had few studies: esmolol (RR 1.02, 95% CI 0.65 to 1.61; I<sup>2</sup> = 0%; 3 studies, 111 participants); timolol (RR 0.55, 95% CI 0.25 to 1.25; I<sup>2</sup> = 0%; 2 studies, 173 participants); and atenolol (RR 0.30, 95% CI 0.05 to 1.90; I<sup>2</sup> = 66%; 2 studies, 139 participants). Analysis of the remaining studies was consistent with the primary analysis: metoprolol (RR 0.72, 95% CI 0.62 to 0.84; I<sup>2</sup> = 5%; 9 studies, 2080 participants); propranolol (RR 0.52, 95% CI 0.33 to 0.81; I<sup>2</sup> = 43%; 9 studies, 896 participants); sotalol (RR 0.45, 95% CI 0.36 to 0.56; I<sup>2</sup> = 15%; 9 studies, 1292 participants); landiolol (RR 0.37, 95% CI 0.26 to 0.52; I<sup>2</sup> = 0%; 5 studies, 578 participants); and acebutolol (RR 0.09, 95% CI 0.01 to 0.66; I<sup>2</sup> = 46%; 2 studies, 171 participants). </p> </li> <li> <p>Bradycardia: we found no evidence of a difference between subgroups (P = 0.30, I<sup>2</sup> = 16.6%; <a href="./references#CD013435-fig-0021" title="">Analysis 2.5</a>). Each type of agent showed little or no difference in incidences of bradycardia, which was consistent with our primary analysis: metoprolol (RR 5.16, 95% CI 0.69 to 38.55; 1 study, 94 participants); propranolol (RR 1.16, 95% CI 0.53 to 2.54; I<sup>2</sup> = 0%; 2 studies, 120 participants); sotalol (RR 2.16, 95% CI 0.70 to 6.65; I<sup>2</sup> = 0%; 4 studies, 736 participants); esmolol (RR 3.00, 95% CI 0.13 to 68.26; 2 studies, 59 participants); landiolol (RR 1.11, 95% CI 0.48 to 2.56; 2 studies, 237 participants); atenolol (RR 0.33, 95% CI 0.01 to 7.91; 1 study, 70 participants); carvedilol (RR 21.11, 95% CI 1.25 to 355.18; 1 study, 324 participants). </p> </li> <li> <p>Hypotension: we found no evidence of a difference between subgroups (P = 0.36, I<sup>2</sup> = 8.7%; <a href="./references#CD013435-fig-0022" title="">Analysis 2.6</a>). Only carvedilol showed an increase in hypotension when beta‐blockers were given, but this evidence was from a single study (RR 5.50, 95% CI 1.25 to 24.20; 324 participants). The remaining agents showed little or no difference in incidences of hypotension, which was consistent with our primary analysis: metoprolol (RR 0.17, 95% CI 0.01 to 4.17; 1 study, 94 participants); propranolol (RR 1.64, 95% CI 0.33 to 8.14; I<sup>2</sup> = 0%; 2 studies, 112 participants); sotalol (RR 0.86, 95% CI 0.20 to 3.74; I<sup>2</sup> = 0%; 4 studies, 736 participants); esmolol (RR 3.00, 95% CI 0.35 to 25.68; 1 study, 30 participants); nadolol (RR 1.66, 95% CI 0.29 to 9.61; 1 study, 141 participants). Only one study reported data for landiolol, in which study authors reported no events (<a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). </p> </li> </ul> </p> </section> </section> <section id="CD013435-sec-0107"> <h4 class="title">Start of beta‐blocker therapy</h4> <p> <ul id="CD013435-list-0013"> <li> <p>Early all‐cause mortality (30 days): we found no evidence of a difference between subgroups according to the time at which beta‐blockers were first given (P = 0.53, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0023" title="">Analysis 3.1</a>). Evidence at each time point was consistent with the primary analysis: before surgery (RR 1.08, 95% CI 0.31 to 3.79; I<sup>2</sup> = 0%; 7 studies, 778 participants); during surgery (RR 0.49, 95% CI 0.13 to 1.90; I<sup>2</sup> = 0%; 4 studies, 371 participants); and after surgery (RR 1.30, 95% CI 0.44 to 3.77; I<sup>2</sup> = 0%; 18 studies, 2950 participants). </p> </li> <li> <p>Acute myocardial infarction: we found no evidence of a difference between subgroups according to the time at which beta‐blockers were first given (P = 0.81, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0024" title="">Analysis 3.2</a>). Evidence at each time point was consistent with the primary analysis: before surgery (RR 1.57, 95% CI 0.45 to 5.45; I<sup>2</sup> = 0%; 2 studies, 246 participants); during surgery (RR 0.95, 95% CI 0.22 to 3.98; I<sup>2</sup> = 0%; 4 studies, 270 participants); after surgery (RR 1.02, 95% CI 0.66 to 1.58; I<sup>2</sup> = 0%; 18 studies, 3106 participants). </p> </li> <li> <p>Ventricular arrhythmias: we found no evidence of a difference between subgroups according to the time at which beta‐blockers were first given (P = 0.72, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0025" title="">Analysis 3.3</a>). We found no evidence of a difference in ventricular arrhythmias when beta‐blockers were given before surgery (RR 0.78, 95% CI 0.13 to 4.55; 291 participants); however, this subgroup included only two studies of which one reported no events. We found only slightly fewer incidences of ventricular arrhythmias when beta‐blockers were given during surgery in four studies (RR 0.42, 95% CI 0.15 to 1.21; I<sup>2</sup> = 37%; 434 participants). Analysis of studies in which beta‐blockers were given after surgery included a larger number of studies and was consistent with the primary analysis (RR 0.36, 95% CI 0.19 to 0.69; I<sup>2</sup> = 0%; 6 studies, 1571 participants). </p> </li> <li> <p>Atrial fibrillation or flutter, or both: we found no evidence of a difference between subgroups according to the time at which beta‐blockers were first given (P = 0.63, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0026" title="">Analysis 3.4</a>). Evidence at each time point was consistent with the primary analysis: before surgery (RR 0.49, 95% CI 0.35 to 0.67; I<sup>2</sup> = 25%; 7 studies, 796 participants); during surgery (RR 0.56, 95% CI 0.43 to 0.74; I<sup>2</sup> = 37%; 10 studies, 1067 participants); and after surgery (RR 0.47, 95% CI 0.37 to 0.60; I<sup>2</sup> = 61%; 23 studies, 3787 participants). </p> </li> <li> <p>Bradycardia: the test for subgroup differences indicated a difference between groups (P = 0.04, I<sup>2</sup> = 68.0%; <a href="./references#CD013435-fig-0027" title="">Analysis 3.5</a>). We found more incidences of bradycardia when beta‐blockers were started before surgery, but this evidence was from few studies with a very wide CI (RR 5.82, 95% CI 1.78 to 19.02; I<sup>2</sup> = 0%; 3 studies, 599 participants). The remaining studies were consistent with the primary analysis and showed little or no difference in bradycardia when beta‐blockers were given during surgery (RR 1.32, 95% CI 0.64 to 2.72; I<sup>2</sup> = 0%; 5 studies, 551 participants), or after surgery (RR 1.01, 95% CI 0.48 to 2.12; I<sup>2</sup> = 0%; 4 studies, 490 participants). </p> </li> <li> <p>Hypotension: we found no evidence of a difference between subgroups according to the time at which beta‐blockers were first given (P = 0.92, I<sup>2</sup> = 0%; <a href="./references#CD013435-fig-0028" title="">Analysis 3.6</a>). Evidence at each time point was consistent with the primary analysis: before surgery (RR 1.85, 95% CI 0.25 to 13.45; I<sup>2</sup> = 57%; 3 studies, 599 participants); during surgery (RR 2.00, 95% CI 0.37 to 10.90; I<sup>2</sup> = 0%; 3 studies, 386 participants); after surgery (RR 1.36, 95% CI 0.45 to 4.12; I<sup>2</sup> = 0%; 4 studies, 553 participants). </p> </li> </ul> </p> </section> <section id="CD013435-sec-0108"> <h4 class="title">Sensitivity analysis</h4> <section id="CD013435-sec-0109"> <h5 class="title">Standard care control</h5> <p> <ul id="CD013435-list-0014"> <li> <p>Early all‐cause mortality (30 days): we excluded 15 studies from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Acute myocardial infarction: we excluded 14 studies from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0035" title="MohrR , SmolinskyA , GoorDA . Prevention of supraventricular tachyarrhythmia with low‐dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery1981;81(6):840‐5. [PUBMED: 7015021] ">Mohr 1981</a>; <a href="./references#CD013435-bbs2-0036" title="MyhreES , SorlieD , AArbakkeJ , HalsPA , StraumeB . Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery1984;25(4):348‐51. [PUBMED: 6148345] ">Myhre 1984</a>; <a href="./references#CD013435-bbs2-0042" title="OkaY , FrishmanW , BeckerRM , KadishA , StromJ , MatsumotoM , et al. Clinical pharmacology of the new beta‐adrenergic blocking drugs. Part 10. Beta‐adrenoceptor blockade and coronary artery surgery. American Heart Journal1980;99(2):255‐69. [PUBMED: 6101516] ">Oka 1980</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Cerebrovascular events: we excluded one study from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Ventricular arrhythmias: we excluded five studies from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Atrial fibrillation or flutter, or both: we excluded 23 studies from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0002" title="AliIM , SanallaAA , ClarkV . Beta‐blocker effects on postoperative atrial fibrillation. European Journal of Cardio‐Thoracic Surgery1997;11(6):1154‐7. [PUBMED: 9237602] ">Ali 1997</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0028" title="LambRK , PrabhakarG , ThorpeJA , SmithS , NortonR , DydeJA . The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. European Heart Journal1988;9(1):32‐6. [PUBMED: 3257915] ">Lamb 1988</a>; <a href="./references#CD013435-bbs2-0031" title="MatangiMF , NeutzeJM , GrahamKJ , HillDG , KerrAR , Barratt‐BoyesBG . Arrhythmia prophylaxis after aorta‐coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery1985;89(3):439‐43. [PUBMED: 3871883] ">Matangi 1985</a>; <a href="./references#CD013435-bbs2-0033" title="MaterneP , LarbuissonR , CollignonP , LimetR , KulbertusH . Prevention by acebutolol of rhythm disorders following coronary bypass surgery. International Journal of Cardiology1985;8(3):275‐83. [PUBMED: 3894250] ">Materne 1985</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0040" title="NyströmU , EdvardssonN , BerggrenH , PizzarelliGP , RadergranK . Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon1993;41(1):34‐7. [PUBMED: 8103611] ">Nyström 1993</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0043" title="OrmerodOJ , McGregorCG , StoneDL , WisbeyC , PetchMC . Arrhythmias after coronary bypass surgery. British Heart Journal1984;51(6):618‐21. [PUBMED: 6610435] ">Ormerod 1984</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0056" title="StephensonLW , MacVaughH , TomaselloDN , JosephsonME . Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery1980;29(2):113‐6. [PUBMED: 6965579] ">Stephenson 1980</a>; <a href="./references#CD013435-bbs2-0062" title="WilliamsJB , StephensonLW , HolfordFD , LangerT , DunkmanWB , JosephsonME . Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery1982;34(4):435‐8. [PUBMED: 6982689 ] ">Williams 1982</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Bradycardia: we excluded two studies from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Hypotension: we excluded one study from analysis in which the control group comparison was standard care (<a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> </ul> </p> </section> <section id="CD013435-sec-0110"> <h5 class="title">Risk of selection bias</h5> <p>Overall, we judged only nine studies to have a low risk of selection bias for sequence generation (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0007" title="BignamiE , GuarnieriM , FrancoA , GerliC , DeLucaM , MonacoF , et al. Esmolol before cardioplegia and as cardioplegia adjuvant reduces cardiac troponin release after cardiac surgery. A randomized trial. Perfusion2017;32(4):313‐20. [PUBMED: 27932571] ">Bignami 2017</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>). This limited sensitivity analysis because there were few remaining studies in analyses once we excluded studies with a high or unclear risk of selection bias. </p> <p> <ul id="CD013435-list-0015"> <li> <p>Early all‐cause mortality (30 days): once we excluded studies with a high or unclear risk of selection bias, only five studies remained in analysis (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>), of which only one study had event data (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>). Meaningful sensitivity analysis could not be conducted for this outcome. </p> </li> <li> <p>Acute myocardial infarction: once we excluded studies with a high or unclear risk of selection bias, only four studies remained in analysis (<a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0060" title="WenkeK , ParsaMH , ImhofM , KemkesBM . Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting. Zeitschrift für Kardiologie1999;88(9):647‐52. [PUBMED: 10525926] ">Wenke 1999</a>). Analysis with only these studies did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Cerebrovascular events: once we excluded studies with a high or unclear risk of selection bias, only one study remained, and this prevented meaningful sensitivity analysis. </p> </li> <li> <p>Ventricular arrhythmias: once we excluded studies with a high or unclear risk of selection bias, only three studies remained in analysis (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>). Whilst analysis without the studies at high or unclear risk of bias showed that fewer participants had incidences of ventricular arrhythmias, the effect was less certain (RR 0.41, 95% CI 0.16 to 1.05). </p> </li> <li> <p>Atrial fibrillation or flutter, or both: once we excluded studies with a high or unclear risk of selection bias, only five studies remained in analysis (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>). Analysis with only these studies did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Bradycardia: once we excluded studies with a high or unclear risk of selection bias, only three studies remained in analysis (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>). Analysis with only these studies did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Hypotension: once we excluded studies with a high or unclear risk of selection bias, only one study remained (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>), and this prevented meaningful sensitivity analysis. </p> </li> </ul> </p> </section> <section id="CD013435-sec-0111"> <h5 class="title">Risk of attrition bias</h5> <p> <ul id="CD013435-list-0016"> <li> <p>Early all‐cause mortality (30 days): we excluded four studies with a high risk of attrition bias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Acute myocardial infarction: we excluded five studies with a high risk of attrition bias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>; <a href="./references#CD013435-bbs2-0024" title="JacquetL , EvenepoelM , MarenneF , EvrardP , VerhelstR , DionR , et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia1994;8(4):431‐6. [PUBMED: 7948800] ">Jacquet 1994</a>; <a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Cerebrovascular events: we found no studies with a high risk of attrition bias for this outcome. </p> </li> <li> <p>Ventricular arrhythmias: we excluded one study with a high risk of attrition bias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Atrial fibrillation or flutter, or both: we excluded five studies with a high risk of attrition bias (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0030" title="MartinussenHJ , LolkA , SzczepanskiC , AlstrupP . Supraventricular tachyarrhythmias after coronary bypass surgery ‐ a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon1988;36(4):206‐7. [PUBMED: 2903581] ">Martinussen 1988</a>; <a href="./references#CD013435-bbs2-0048" title="RubinDA , NieminskiKE , ReedGE , HermanMV . Predictors, prevention, and long‐term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery1987;94(3):331‐5. [PUBMED: 3306163] ">Rubin 1987</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Bradycardia: we excluded one study with a high risk of attrition bias (<a href="./references#CD013435-bbs2-0005" title="Babin‐EbellJ , KeithPR , ElertO . Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio‐Thoracic Surgery1996;10(6):412‐6. [PUBMED: 8817135] ">Babin‐Ebell 1996</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Hypotension: we excluded one study with a high risk of attrition bias (<a href="./references#CD013435-bbs2-0026" title="KhuriSF , OkikeN , JosaM , SalmTJ , AssoussaS , LeoneL , et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology1987;60(6):51‐8D. [PUBMED: 3498356] ">Khuri 1987</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> </ul> </p> </section> <section id="CD013435-sec-0112"> <h5 class="title">Beta‐blockers given as rescue therapy</h5> <p> <ul id="CD013435-list-0017"> <li> <p>Early all‐cause mortality (30 days): we excluded seven studies in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Acute myocardial infarction: we excluded seven studies in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Cerebrovascular events: we excluded two studies in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Ventricular arrhythmias: we excluded four studies in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Atrial fibrillation or flutter, or both: we excluded nine studies in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0001" title="AbelRM , VanGelderHM , PoresIH , LiguoriJ , GielchinskyI , ParsonnetV . Continued propranolol administration following coronary bypass surgery. Antiarrhythmic effects. Archives of Surgery1983;118(6):727‐31. [PUBMED: 6601941] ">Abel 1983</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0012" title="DaudonP , CorcosT , GandjabakhchI , LevasseurJP , CabrolA , CabrolC . Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology1986;58(10):933‐6. [PUBMED: 3535474] ">Daudon 1986</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0025" title="JanssenJ , LoomansL , HarinkJ , TaamsM , BrunninkhuisL , Van derStarreP , et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology1986;37(8):601‐9. [PUBMED: 2874755] ">Janssen 1986</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>; <a href="./references#CD013435-bbs2-0050" title="SalazarC , FrishmanW , FriedmanS , PatelJ , LinYT , OkaY , et al. Beta‐blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology1979;30(12):816‐9. [PUBMED: 316976] ">Salazar 1979</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0054" title="SilvermanNA , WrightR , LevitskyS . Efficacy of low‐dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery1982;196(2):194‐7. [PUBMED: 6979982] ">Silverman 1982</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Bradycardia: we excluded two studies in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0021" title="HammonJW , WoodAJ , PragerRL , WoodM , MuirheadJ , BenderHWJr . Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery1984;38(4):363‐7. [PUBMED: 6385890] ">Hammon 1984</a>; <a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Hypotension: we excluded one study in which participants in the control group were given beta‐blockers as rescue therapy (<a href="./references#CD013435-bbs2-0046" title="PfistererME , Klöter‐WeberUC , HuberM , OsswaldS , BuserPT , SkarvanK , et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low‐dose sotalol: a prospective, double‐blind, randomized, placebo‐controlled study. Annals of Thoracic Surgery1997;64(4):1113‐9. [PUBMED: 9354537] ">Pfisterer 1997</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> </ul> </p> </section> <section id="CD013435-sec-0113"> <h5 class="title">Studies published before 2000</h5> <p> <ul id="CD013435-list-0018"> <li> <p>Early all‐cause mortality (30 days): we included in analysis only studies published since 2000 (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Acute myocardial infarction: we included in analysis only studies published since 2000 (<a href="./references#CD013435-bbs2-0006" title="BertA , ReinertSE , SinghAK . A beta‐blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):204‐9. [PUBMED: 11312480] ">Bert 2001</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Cerebrovascular events: only one study was published before 2000, and we excluded this study (<a href="./references#CD013435-bbs2-0032" title="MatangiMF , StricklandJ , GarbeGJ , HabibN , BasuA , BurgessJJ , et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology1989;5(4):229‐34. [PUBMED: 2659151] ">Matangi 1989</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Ventricular arrhythmias: we included in analysis only studies published since 2000 (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Atrial fibrillation or flutter, or both: we included in analysis only studies published since 2000 (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0010" title="ConnollySJ , CybulskyI , LamyA , RobertsRS , TechM , O'BrienB , et al. Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta‐blocker length of stay (BLOS) study. American Heart Journal2003;145(2):226‐32. [PUBMED: 12595838] ">Connolly 2003</a>; <a href="./references#CD013435-bbs2-0013" title="DeAzevedo LúcioE , FloresA , BlacherC , LeaesPE , LuccheseFA , Pinto RibeiroJ . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arquivos Brasileiros de Cardiologia2003;82(1):37‐41. [PUBMED: 14978593] ">De Azevedo Lúcio 2003</a>; <a href="./references#CD013435-bbs2-0015" title="EvrardP , GonzalezM , JamartJ , MalhommeB , BlommaertD , EucherP , et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low‐dose sotalol. Annals of Thoracic Surgery2000;70(1):151‐6. [PUBMED: 10921700] ">Evrard 2000</a>; <a href="./references#CD013435-bbs2-0016" title="ForlaniS , DePaulisR , DeNotarisS , NardiP , TomaiF , ProiettiI , et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery2002;74(3):720‐6. [PUBMED: 12238830] ">Forlani 2002</a>; <a href="./references#CD013435-bbs2-0029" title="LiuX , ShaoF , YangL , JiaY . A pilot study of perioperative esmolol for myocardial protection during on‐pump cardiac surgery. Experimental and Therapeutic Medicine2016;12(5):2990‐6. [PUBMED: 27882105] ">Liu 2016</a>; <a href="./references#CD013435-bbs2-0034" title="MatsuuraK , TakaharaY , SudoY , IshidaK . Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery2001;49(10):614‐7. [PUBMED: 11692587] ">Matsuura 2001</a>; <a href="./references#CD013435-bbs2-0037" title="NetoRJ , GunC , RamosRF , DeAlmeidaAF , IssaM , AmatoVL , et al. Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I. Brazilian Journal of Cardiovascular Surgery2013;28(4):449‐54. [PUBMED: 24598948] ">Neto 2013</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0044" title="OsadaH , NakajimaH , MasuyamaS , MorishimaM , SuT . Landiolol hydrochloride: prevention of atrial fibrillation after open‐heart surgery. European Heart Journal2012;33(Suppl 1):65. ">Osada 2012</a>; <a href="./references#CD013435-bbs2-0049" title="SakaguchiM , SasakiY , HiraiH , HosonoM , NakahiraA , SeoH , et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal2012;53(6):359‐63. [PUBMED: 23258136] ">Sakaguchi 2012</a>; <a href="./references#CD013435-bbs2-0052" title="SezaiA , MinamiK , NakaiT , HataM , YoshitakeI , WakuiS , et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery2011;141(6):1478‐87. [PUBMED: 21269646] ">Sezai 2011</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>; <a href="./references#CD013435-bbs2-0055" title="SkibaMA , PickAW , ChaudhuriK , BaileyM , KrumH , KwaLJ , et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung and Circulation2013;22(8):627‐33. [PUBMED: 23465653] ">Skiba 2013</a>; <a href="./references#CD013435-bbs2-0057" title="SunJ , DingZ , QianY . Effect of short‐acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery2011;6(99):no pagination. [PUBMED: 21854625] ">Sun 2011</a>; <a href="./references#CD013435-bbs2-0063" title="YaziciogluL , EryilmazS , SirlakM , InanMB , AralA , TasozR , et al. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. European Journal of Cardio‐Thoracic Surgery2002;22(3):397‐401. [PUBMED: 12204730] ">Yazicioglu 2002</a>). This did not alter the interpretation of the effect for this outcome. </p> </li> <li> <p>Bradycardia: we included in analysis only studies published since 2000 (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0041" title="OgawaS , OkawaY , GotoY , AokiM , BabaH . Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals2013;21(3):265‐9. [PUBMED: 24570490] ">Ogawa 2013</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). Whilst the effect continued to show little or no difference between groups in the incidence of bradycardia, we noted that the CI was much wider when analysis included fewer and only more recently published studies (RR 3.11, 95% CI 0.81 to 11.95). </p> </li> <li> <p>Hypotension: we included in analysis only studies published since 2000 (<a href="./references#CD013435-bbs2-0004" title="AuerJ , WeberT , BerentR , PuschmannR , HartlP , NgC , et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo‐controlled trial. American Heart Journal2004;147(4):636‐43. [PUBMED: 15077078] ">Auer 2004</a>; <a href="./references#CD013435-bbs2-0009" title="ButAK , YapiciE , ErdilF , ÖztürkE , GedikE , DurmusM , et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery. Gogus‐Kalp‐Damar Anestezi ve Yogun Bakim Dernegi Dergesi2006;124(4):143‐8. ">But 2006</a>; <a href="./references#CD013435-bbs2-0051" title="SerruysPW , FoleyDP , HoflingB , PuelJ , GlogarHD , Seabra‐GomesR , et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation2000;101(13):1512‐8. [PUBMED: 10747343] ">Serruys 2000</a>; <a href="./references#CD013435-bbs2-0053" title="SezaiA , NakaiT , HataM , YoshitakeI , ShionoM , KunimotoS , et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery2012;144(5):1241‐8. [PUBMED: 22858430] ">Sezai 2012</a>). Whilst the effect continued to show little or no difference between groups in the incidence of hypotension, we noted that the CI was much wider when analysis included fewer and only more recently published studies (RR 1.95, 95% CI 0.35 to 10.99). </p> </li> </ul> </p> </section> <section id="CD013435-sec-0114"> <h5 class="title">Outcomes with rare events</h5> <p> <ul id="CD013435-list-0019"> <li> <p>In studies reporting all‐cause mortality, fewer than 1% participants had an event within 30 days. In sensitivity analysis, we used Peto odds ratio. This did not alter the interpretation of the effect. </p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013435-sec-0115" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013435-sec-0115">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013435-sec-0166">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013435-sec-0115"></div> <section id="CD013435-sec-0116"> <h3 class="title" id="CD013435-sec-0116">Summary of main results</h3> <p>We found 63 studies in which beta‐blockers were given during the perioperative period to adults undergoing cardiac surgery. In addition, we identified four studies awaiting classification (two are reported only as an abstract and two are completed trials; we await publication of the full reports for these studies) and two ongoing studies. </p> <p>We found low‐certainty evidence that beta‐blockers make little or no difference to all‐cause mortality within 30 days, however, we found few deaths in the control and the beta‐blocker groups. We found no evidence of a difference in the number of people who have an acute myocardial infarction (low‐certainty evidence). We were uncertain whether these agents make little or no difference to cerebrovascular events because we assessed the certainty of the evidence to be very low. We found low‐certainty evidence that taking beta‐blockers perioperatively may reduce ventricular arrhythmias and atrial fibrillation or flutter. Beta‐blockers may make little or no difference to hypotension or bradycardia; although we assessed the evidence for these outcomes to be low certainty. </p> <p>We found little or no difference in long‐term mortality from two studies, as well as little or no difference in death due to cardiac causes in four studies. Similarly, we found little or no difference in the number of people who had congestive failure in three studies. However, we assessed the certainty of the evidence for these outcomes to be very low. We found low‐certainty evidence that length of stay was shorter when participants were treated with beta‐blockers but analysis identified moderate statistical heterogeneity; we did not explore reasons for this heterogeneity through further subgroup analysis. No studies assessed quality of life. </p> </section> <section id="CD013435-sec-0117"> <h3 class="title" id="CD013435-sec-0117">Overall completeness and applicability of evidence</h3> <p>We identified 63 studies with 7768 participants, of which ten were identified in the most recent search. All studies were in adult participants undergoing cardiac surgery. </p> <p>Because of the type of surgery, we assumed that all participants were at high risk of cardiac complications. We noted differences between studies with regard to whether participants were taking beta‐blockers preoperatively, and previous history of conditions such as hypertension or myocardial infarctions. However, these differences would be consistent with a general population of people scheduled to undergo cardiac surgery. </p> <p>We included in the review several studies published prior to 2000, and these studies may have used clinical management strategies that differ from current practice. We explored this in sensitivity analysis but found no changes to the interpretation of the effect for the main review outcomes when we included only studies published since 2000. </p> <p>For most outcomes, we noted little evidence of heterogeneity in the effects. Exploration of subgroups according to the type of beta‐blocker or whether the intervention was given before, during, or after surgery did not strongly demonstrate that these differences were likely to influence the results. </p> </section> <section id="CD013435-sec-0118"> <h3 class="title" id="CD013435-sec-0118">Quality of the evidence</h3> <p>We used GRADE to assess the certainty of the evidence. In a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>), we calculated optimal information sizes for each outcome and we used these calculations in the current update to assess that we had insufficient numbers of participants for our main outcomes (except for atrial fibrillation). In addition, we noted a wide confidence interval for the effects in some outcomes. Subsequently, we downgraded the certainty of the evidence owing to imprecision. </p> <p>In general, we found that very few included studies had used adequate reporting methods to describe methods of sequence generation and allocation concealment, and none of the included studies were prospectively registered with clinical trial registers. Many studies compared perioperative beta‐blockers with standard care rather than with a placebo and this open‐label study design introduced performance bias which was not present in most of the placebo‐controlled trials. We noted that some studies allowed clinicians to use beta‐blockers to treat arrhythmias regardless of the study group to which participants were allocated; therefore, in some studies participants in the control group received beta‐blockers as rescue therapy during the study period. We downgraded the certainty of the evidence owing to these study limitations. </p> </section> <section id="CD013435-sec-0119"> <h3 class="title" id="CD013435-sec-0119">Potential biases in the review process</h3> <p>Our previous review assessed beta‐blockers in both cardiac and non‐cardiac surgery (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>); we split this review into two reviews according to type of surgery. This version incorporates data from studies of cardiac surgery and includes an updated search. We conducted a thorough search in the update and used two review authors to assess study eligibility, extract data, and assess risk of bias in included studies; therefore, we reduced potential bias in the review process. </p> <p>During the updating process, we made changes to the review to meet current Cochrane standards. This included minor clarifications to the inclusion criteria of the review, and changes to the wording of the sections of the methods within <a href="#CD013435-sec-0061">Data collection and analysis</a>. In particular, this version of the review includes fewer outcomes. Data for myocardial ischaemia, supraventricular arrhythmias (except atrial fibrillation or flutter), bronchospasm and cost of care are reported only in the previous version (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). In reducing the number of outcomes, our intention was to improve the usability of the review; therefore, we selected outcomes that we considered to be most important to users of the review. We used the work of Myles and colleagues to support this decision‐making process (<a href="./references#CD013435-bbs2-0105" title="MylesPS , GrocottMP , BoneyO , MoonesingheSR , COMPAC‐StEP Group. Standardizing end points in perioperative trials: towards a core and extended outcome set. British Journal of Anaesthesia2016;116(5):586‐9. [PUBMED: 27106961] ">Myles 2016</a>), and sought advice from a Cochrane Editor before agreeing to a reduction in outcomes. </p> <p>In addition, we did not include meta‐regression as a method to explore heterogeneity in this review. We explored heterogeneity only through subgroup analysis that we decided in the review protocol. We conducted analyses using a random‐effects model, rather than choosing the effects model based on statistical heterogeneity (<a href="./references#CD013435-bbs2-0083" title="BorensteinM , HedgesLV , HigginsJP , RothsteinHR . A basic introduction to fixed‐effect and random‐effects models for meta‐analysis. Research Synthesis Methods2010;1(2):97‐111. [PUBMED: 26061376] ">Borenstein 2010</a>); we evaluated in sensitivity analysis the effect of using Peto odds ratio for rare events, which uses a fixed‐effect model. Again, we made these decisions following advice from the Cochrane Editorial team. </p> <p>We included only trials that investigated at least one outcome specified in the Methods section. Because of the vast scope of the literature search and the large number of search results and included trials, this approach was justified in order to improve the management of the review. Whilst this may have introduced a source of bias, we judged the impact of potentially missing studies as small because the available set of data was derived from a large number of trials. </p> <p>Whilst we attempted to collect definitions of outcomes from study reports (e.g. for hypotension), we could not account for the variation in individual clinical management of participants in which agents such as vasopressors or inotropes may affect outcome definition. We also found that some studies did not specify a definition of all outcomes. </p> <p>Furthermore, we could not contact all study authors to gather further information about trial design or data analysis (e.g. performance of an intention‐to‐treat analysis) because of the large number of studies. However, it is likely that study authors, if contacted, may over report trial design quality criteria. </p> </section> <section id="CD013435-sec-0120"> <h3 class="title" id="CD013435-sec-0120">Agreements and disagreements with other studies or reviews</h3> <p>The addition of 10 new studies in this update did not alter the interpretation of our findings; these results are consistent with those reported for cardiac surgery in the previous version of this review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). They are also largely consistent with those of other systematic reviews which include both RCTs and observational studies (<a href="./references#CD013435-bbs2-0087" title="CrystalE , ConnollySJ , SleikK , GingerTJ , YusufS . Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta‐analysis. Circulation2002;106(1):75‐80. [PUBMED: 12093773] ">Crystal 2002</a>; <a href="./references#CD013435-bbs2-0111" title="TamuraT , YatabeT , YokoyamaM . Prevention of atrial fibrillation after cardiac surgery using low‐dose landiolol: a systematic review and meta‐analysis. Journal of Clinical Anesthesia2017;42:1‐6. [617384012; PUBMED: 28962938] ">Tamura 2017</a>; <a href="./references#CD013435-bbs2-0113" title="TheinPM , WhiteK , BankerK , LunnyC , MirzaeeS , NasisA . Preoperative use of oral beta‐adrenergic blocking agents and the incidence of new‐onset atrial fibrillation after cardiac surgery. A systematic review and meta‐analysis. Heart Lung and Circulation2018;27(3):310‐21. [619169404; PUBMED: 29129562] ">Thein 2018</a>; <a href="./references#CD013435-bbs2-0114" title="WangLS , WangH , HouXT . Short‐term effects of preoperative beta‐blocker use for isolated coronary artery bypass grafting: a systematic review and meta‐analysis. Journal of Thoracic and Cardiovascular Surgery2018;155(2):620‐9. [PUBMED: 28918203] ">Wang 2018</a>). </p> <p>We identified moderate statistical heterogeneity in the effect estimate for atrial fibrillation or flutter, and this heterogeneity was not present in most of our other outcomes. We were unable to explain this inconsistency in the data, and noted that another large systematic review similarly reported unexplained heterogeneity for this outcome (<a href="./references#CD013435-bbs2-0087" title="CrystalE , ConnollySJ , SleikK , GingerTJ , YusufS . Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta‐analysis. Circulation2002;106(1):75‐80. [PUBMED: 12093773] ">Crystal 2002</a>). </p> <p>A reduction in heart rate and blood pressure are inherent properties of beta‐blockers, and it could be argued that it is expected that use of beta‐blockers during the perioperative period would induce bradycardia and hypotension. However, people undergoing cardiac surgery, in particular, are likely to be under stricter controls to keep haemodynamic variables stable within a small range; we could not always ascertain whether and how participants were managed in all studies and could not be certain whether other clinical management may have influenced the results for bradycardia and hypotension. </p> <p>Although we used subgroup analysis to assess the effects of the type of beta‐blocker or the time at which the treatment was initiated, we were not confident in the findings from this analysis. Any differences between the primary analyses and subgroup analyses were in subgroups for which there were very few studies and participants and subsequently, the effect was much less precise. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013435-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for updated search on 28 June 2019" data-id="CD013435-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram for updated search on 28 June 2019</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD013435-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD013435-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.1 All‐cause mortality (30 days)" data-id="CD013435-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.1 All‐cause mortality (30 days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.7 Atrial fibrillation or flutter, or both" data-id="CD013435-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison 1. Beta‐blocker vs control for cardiac surgery, outcome: 1.7 Atrial fibrillation or flutter, or both </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 1 All‐cause mortality (30 days)." data-id="CD013435-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 1 All‐cause mortality (30 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 2 Long‐term mortality." data-id="CD013435-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 2 Long‐term mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 3 Death due to cardiac causes." data-id="CD013435-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 3 Death due to cardiac causes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 4 Acute myocardial infarction." data-id="CD013435-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 4 Acute myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 5 Cerebrovascular events." data-id="CD013435-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 5 Cerebrovascular events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 6 Ventricular arrhythmias." data-id="CD013435-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 6 Ventricular arrhythmias.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 7 Atrial fibrillation or flutter, or both." data-id="CD013435-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 7 Atrial fibrillation or flutter, or both. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 8 Bradycardia." data-id="CD013435-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 8 Bradycardia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 9 Hypotension." data-id="CD013435-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 9 Hypotension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 10 Congestive heart failure." data-id="CD013435-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 10 Congestive heart failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 11 Length of hospital stay (in days)." data-id="CD013435-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Beta‐blocker vs control for cardiac surgery, Outcome 11 Length of hospital stay (in days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 1 All‐cause mortality (30 days)." data-id="CD013435-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 1 All‐cause mortality (30 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 2 Acute myocardial infarction." data-id="CD013435-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 2 Acute myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 3 Ventricular arrhythmias." data-id="CD013435-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 3 Ventricular arrhythmias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 4 Atrial fibrillation and flutter." data-id="CD013435-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 4 Atrial fibrillation and flutter. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 5 Bradycardia." data-id="CD013435-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 5 Bradycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 6 Hypotension." data-id="CD013435-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker, Outcome 6 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 1 All‐cause mortality (30 days)." data-id="CD013435-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 1 All‐cause mortality (30 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 2 Acute myocardial infarction." data-id="CD013435-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 2 Acute myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 3 Ventricular arrhythmias." data-id="CD013435-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 3 Ventricular arrhythmias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 4 Atrial fibrillation and flutter." data-id="CD013435-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 4 Atrial fibrillation and flutter. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 5 Bradycardia." data-id="CD013435-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 5 Bradycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013435-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/urn:x-wiley:14651858:media:CD013435:CD013435-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_t/tCD013435-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 6 Hypotension." data-id="CD013435-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy, Outcome 6 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013435/media/CDSR/CD013435/image_n/nCD013435-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013435-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Beta‐blockers compared to placebo or standard care for preventing perioperative mortality and morbidity in adults undergoing cardiac surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Population:</b> adults undergoing cardiac surgery under general anaesthesia<br/> <b>Setting:</b> hospitals in: Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, UK, USA<br/> <b>Intervention:</b> beta‐blockers (metoprolol, propranolol, sotalol, esmolol, timolol, landiolol, nadolol, acebutolol, atenolol)<br/> <b>Comparison:</b> placebo or standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with beta‐blockers</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95</p> <p>(0.47 to 1.90)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4099<br/> (29 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000<br/> (3 to 14) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acute myocardial infarction</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.72 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3946<br/> (25 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/> (21 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cerebrovascular events</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(RR 1.37, 95% CI 0.51 to 3.67)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1471<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000<br/> (5 to 36) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Ventricular arrhythmias</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/> (0.25 to 0.63) </p> <p>NNTB: 31 (25 to 50)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2296<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (13 to 34) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Atrial fibrillation or flutter, or both</b> </p> <p>(within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/> (0.42 to 0.59) </p> <p>NNTB: 6 (5 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5650<br/> (40 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>327 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>164 per 1000<br/> (137 to 193) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Bradycardia</b> </p> <p>(within 30 days; as defined by study authors, minimum heart rate &lt; 60 beats per minute or requiring medication) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.63<br/> (0.92 to 2.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1640<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000<br/> (27 to 87) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypotension</b> </p> <p>(within 30 days; as defined by study authors, minimum systolic blood pressure &lt; 90 mmHg or requiring medication) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.84<br/> (0.89 to 3.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1538<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (14 to 58) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>NNTB:</b> number needed to treat for an additional beneficial outcome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain; and one level for imprecision owing to a wide CI in the effect estimate and because the evidence was from too few participants; our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>).<br/> <sup>b</sup>We downgraded by three levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and two levels for imprecision owing to the very wide CI in the effect estimate and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>).<br/> <sup>c</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and one level for imprecision because the evidence was from too few participants; our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>).<br/> <sup>d</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias; and one level for inconsistency owing to moderate level of statistical heterogeneity which we were unable to explain through subgroup analysis.<br/> <sup>e</sup>We downgraded by two levels: one level for study limitations owing to the inclusion of several studies at high risk of bias in at least one domain; and one level for imprecision owing to the very wide confidence interval and because the evidence was from too few participants. Our estimate for the required number of participants was taken from a calculation in a previous version of the review (<a href="./references#CD013435-bbs2-0117" title="BlessbergerH , KammlerJ , DomanovitsH , SchlagerO , WildnerB , AzarD , et al. Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity. Cochrane Database of Systematic Reviews2018, Issue 3. [DOI: 10.1002/14651858.CD004476.pub3] ">Blessberger 2018</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013435/full#CD013435-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013435-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Beta‐blocker vs control for cardiac surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality (30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4099</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.47, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Long‐term mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.29, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death due to cardiac causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.14, 5.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Acute myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3946</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.72, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cerebrovascular events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.51, 3.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Ventricular arrhythmias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.25, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Atrial fibrillation or flutter, or both <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.42, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.92, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.89, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.04, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Length of hospital stay (in days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐0.90, ‐0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Beta‐blocker vs control for cardiac surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013435-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality (30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3889</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.49, 2.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Metoprolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.44, 6.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Propranolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.19, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Sotalol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1037</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.08, 5.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Esmolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.65 [0.12, 60.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Timolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.12, 66.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Landiolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Atenolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.13, 71.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Acute myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.68, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Metoprolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.91, 4.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Propranolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1088</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.43, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Sotalol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>643</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.07, 4.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Esmolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Nadolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.02, 8.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Landiolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.57 [0.13, 52.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Acebutolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Atenolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.32, 5.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Ventricular arrhythmias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.25, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Metoprolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1094</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.06, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Propranolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>592</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.21, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Sotalol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.38 [0.40, 14.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Esmolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.08, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Atenolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Atrial fibrillation and flutter <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.43, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Metoprolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2080</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.62, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Propranolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.33, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Sotalol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.36, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Esmolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.65, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 Atenolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.05, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Landiolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>578</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.26, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Acebutolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8 Timolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.25, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.93, 2.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Metoprolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.69, 38.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Propranolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.53, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Sotalol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.16 [0.70, 6.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Esmolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.13, 68.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Landiolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.48, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Atenolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Carvedilol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.11 [1.25, 355.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [0.87, 3.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Metoprolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Propranolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [0.33, 8.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Sotalol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.20, 3.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Esmolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.35, 25.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Landiolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Carvedilol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.50 [1.25, 24.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7 Nadolol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [0.29, 9.61]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Beta‐blocker vs control for cardiac surgery: subgroup by type of beta‐blocker</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013435-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality (30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4099</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.47, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Before surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.31, 3.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 During surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.13, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 After surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.44, 3.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Acute myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.72, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Before surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.45, 5.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 During surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.22, 3.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 After surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.66, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Ventricular arrhythmias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.25, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Before surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.13, 4.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 During surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.15, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 After surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.19, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Atrial fibrillation and flutter <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.42, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Before surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>796</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.35, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 During surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1067</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.43, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 After surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3787</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.37, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.92, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Before surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.82 [1.78, 19.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 During surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.64, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 After surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.48, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.89, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Before surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [0.25, 13.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 During surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.37, 10.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 After surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>553</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.45, 4.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Beta‐blocker vs control for cardiac surgery: subgroup by start of beta‐blocker therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013435/references#CD013435-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013435&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013435-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013435-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013435-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013435-note-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ko#CD013435-note-0001">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013435-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013435-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013435\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013435"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013435\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013435\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013435"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013435\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013435"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013435\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013435\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013435"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013435&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013435';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013435/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013435/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013435%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729680709"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013435/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729680713"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013435/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee2cefe0e9377',t:'MTc0MDcyOTY4MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 